| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acute Kidney Injury | 120 | 2024 | 1925 | 12.320 |
Why?
|
| Kidney | 156 | 2024 | 7046 | 8.060 |
Why?
|
| Kidney Tubules, Proximal | 44 | 2021 | 383 | 6.120 |
Why?
|
| Kidney Tubules | 42 | 2023 | 449 | 5.790 |
Why?
|
| Phospholipases A | 56 | 2007 | 204 | 5.130 |
Why?
|
| Kidney Diseases | 45 | 2022 | 2093 | 4.370 |
Why?
|
| Pluripotent Stem Cells | 13 | 2024 | 800 | 3.790 |
Why?
|
| Reperfusion Injury | 43 | 2024 | 1023 | 3.660 |
Why?
|
| Receptors, Virus | 37 | 2015 | 640 | 3.310 |
Why?
|
| Group IV Phospholipases A2 | 26 | 2015 | 58 | 3.250 |
Why?
|
| Renal Insufficiency, Chronic | 37 | 2024 | 2241 | 3.210 |
Why?
|
| Cell Adhesion Molecules | 31 | 2014 | 1600 | 3.210 |
Why?
|
| Membrane Glycoproteins | 37 | 2015 | 3701 | 3.060 |
Why?
|
| Ischemia | 45 | 2020 | 1876 | 2.610 |
Why?
|
| Nephrons | 9 | 2023 | 168 | 2.570 |
Why?
|
| Creatinine | 39 | 2023 | 1898 | 2.440 |
Why?
|
| Diabetic Nephropathies | 17 | 2021 | 973 | 2.320 |
Why?
|
| Cytosol | 41 | 2015 | 888 | 2.130 |
Why?
|
| Ischemic Preconditioning | 9 | 2015 | 89 | 2.100 |
Why?
|
| Kidney Failure, Chronic | 21 | 2023 | 2462 | 2.010 |
Why?
|
| Organoids | 12 | 2024 | 741 | 1.940 |
Why?
|
| Epithelial Cells | 32 | 2024 | 3661 | 1.820 |
Why?
|
| Membrane Proteins | 31 | 2018 | 7849 | 1.690 |
Why?
|
| Acetylglucosaminidase | 12 | 2018 | 66 | 1.590 |
Why?
|
| Renal Circulation | 20 | 2015 | 291 | 1.570 |
Why?
|
| Phagocytosis | 10 | 2018 | 1536 | 1.540 |
Why?
|
| Nephrology | 6 | 2014 | 263 | 1.440 |
Why?
|
| Fibrosis | 29 | 2022 | 2048 | 1.400 |
Why?
|
| Cisplatin | 17 | 2021 | 1647 | 1.380 |
Why?
|
| Glomerular Mesangium | 16 | 2005 | 98 | 1.340 |
Why?
|
| Animals | 304 | 2022 | 168253 | 1.330 |
Why?
|
| Lipocalins | 17 | 2018 | 161 | 1.180 |
Why?
|
| Regeneration | 14 | 2022 | 1508 | 1.140 |
Why?
|
| Mitogen-Activated Protein Kinases | 20 | 2007 | 1246 | 1.130 |
Why?
|
| Phospholipases A2 | 44 | 2011 | 197 | 1.120 |
Why?
|
| Renal Insufficiency | 6 | 2014 | 809 | 1.100 |
Why?
|
| Renal Replacement Therapy | 8 | 2019 | 281 | 1.020 |
Why?
|
| Kidney Glomerulus | 13 | 2022 | 567 | 1.010 |
Why?
|
| Acute-Phase Proteins | 15 | 2015 | 250 | 0.990 |
Why?
|
| Mice | 139 | 2022 | 81402 | 0.970 |
Why?
|
| G2 Phase | 2 | 2015 | 136 | 0.960 |
Why?
|
| Renal Dialysis | 13 | 2014 | 1795 | 0.910 |
Why?
|
| Glomerular Filtration Rate | 26 | 2023 | 2171 | 0.890 |
Why?
|
| Rats | 111 | 2017 | 23712 | 0.880 |
Why?
|
| Glomerulonephritis | 5 | 2012 | 336 | 0.850 |
Why?
|
| Calcium | 49 | 2013 | 5726 | 0.850 |
Why?
|
| Arachidonic Acid | 23 | 2015 | 427 | 0.840 |
Why?
|
| Proteinuria | 12 | 2017 | 600 | 0.820 |
Why?
|
| Heat-Shock Proteins | 13 | 2007 | 795 | 0.820 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 5 | 2016 | 166 | 0.820 |
Why?
|
| Albuminuria | 11 | 2023 | 650 | 0.810 |
Why?
|
| Cell Differentiation | 20 | 2024 | 11526 | 0.770 |
Why?
|
| COUP Transcription Factor II | 1 | 2021 | 18 | 0.770 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2021 | 63 | 0.740 |
Why?
|
| TRPP Cation Channels | 5 | 2016 | 177 | 0.730 |
Why?
|
| Ataxia Telangiectasia | 1 | 2021 | 107 | 0.730 |
Why?
|
| Humans | 281 | 2024 | 760437 | 0.710 |
Why?
|
| Zinc Fingers | 9 | 2001 | 572 | 0.700 |
Why?
|
| National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 4 | 2022 | 26 | 0.680 |
Why?
|
| Ureter | 1 | 2022 | 367 | 0.680 |
Why?
|
| Kidney Function Tests | 10 | 2022 | 675 | 0.680 |
Why?
|
| Disease Progression | 27 | 2021 | 13484 | 0.670 |
Why?
|
| Mice, Knockout | 41 | 2022 | 14397 | 0.660 |
Why?
|
| Cyclin G1 | 1 | 2019 | 15 | 0.660 |
Why?
|
| Biomarkers, Pharmacological | 2 | 2010 | 162 | 0.660 |
Why?
|
| Cell Compartmentation | 2 | 2019 | 384 | 0.650 |
Why?
|
| Mice, Inbred BALB C | 21 | 2021 | 6206 | 0.640 |
Why?
|
| Mesoderm | 3 | 2013 | 673 | 0.640 |
Why?
|
| Cadmium | 3 | 2009 | 213 | 0.630 |
Why?
|
| Diabetes Mellitus, Type 1 | 8 | 2021 | 3439 | 0.630 |
Why?
|
| Apoptosis | 29 | 2017 | 9468 | 0.630 |
Why?
|
| Dinoprostone | 16 | 2015 | 597 | 0.620 |
Why?
|
| Disease Models, Animal | 30 | 2021 | 18216 | 0.620 |
Why?
|
| Postmortem Changes | 1 | 2018 | 119 | 0.620 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2019 | 2058 | 0.620 |
Why?
|
| Cell Division | 11 | 2015 | 4461 | 0.620 |
Why?
|
| Proto-Oncogene Proteins | 23 | 2015 | 4509 | 0.610 |
Why?
|
| Cytokines | 12 | 2021 | 7377 | 0.600 |
Why?
|
| Rats, Sprague-Dawley | 38 | 2014 | 8163 | 0.590 |
Why?
|
| Isoenzymes | 11 | 2013 | 1688 | 0.590 |
Why?
|
| Gentamicins | 8 | 2012 | 251 | 0.590 |
Why?
|
| Adenosine Triphosphate | 14 | 2024 | 1989 | 0.580 |
Why?
|
| Transcription Factors | 23 | 2020 | 12121 | 0.550 |
Why?
|
| LLC-PK1 Cells | 7 | 2019 | 125 | 0.550 |
Why?
|
| Inflammation | 22 | 2023 | 10746 | 0.550 |
Why?
|
| Chemokine CCL2 | 8 | 2021 | 604 | 0.550 |
Why?
|
| DNA Damage | 4 | 2021 | 2441 | 0.540 |
Why?
|
| G1 Phase | 3 | 2015 | 403 | 0.540 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2018 | 1857 | 0.520 |
Why?
|
| Mice, Inbred C57BL | 37 | 2022 | 22121 | 0.520 |
Why?
|
| Autophagy | 4 | 2019 | 1319 | 0.520 |
Why?
|
| Meclizine | 1 | 2015 | 13 | 0.520 |
Why?
|
| Male | 174 | 2024 | 360035 | 0.520 |
Why?
|
| DNA Repair | 4 | 2019 | 2044 | 0.510 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2013 | 499 | 0.500 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 6 | 2022 | 256 | 0.500 |
Why?
|
| Germ Layers | 1 | 2015 | 72 | 0.500 |
Why?
|
| Glycocalyx | 1 | 2016 | 95 | 0.500 |
Why?
|
| Cyclooxygenase 2 | 10 | 2013 | 597 | 0.500 |
Why?
|
| Nephrectomy | 6 | 2024 | 934 | 0.500 |
Why?
|
| Adult Stem Cells | 2 | 2008 | 221 | 0.490 |
Why?
|
| Sirtuin 2 | 1 | 2015 | 95 | 0.490 |
Why?
|
| Macrophages, Peritoneal | 8 | 2013 | 236 | 0.490 |
Why?
|
| Microvessels | 2 | 2016 | 574 | 0.480 |
Why?
|
| Protective Agents | 2 | 2015 | 150 | 0.480 |
Why?
|
| Cell Culture Techniques | 6 | 2024 | 1667 | 0.470 |
Why?
|
| Metaphase | 1 | 2014 | 145 | 0.470 |
Why?
|
| Kidney Tubular Necrosis, Acute | 4 | 2004 | 65 | 0.470 |
Why?
|
| Forkhead Transcription Factors | 4 | 2022 | 1611 | 0.470 |
Why?
|
| Receptors, Death Domain | 1 | 2014 | 31 | 0.470 |
Why?
|
| Intercellular Adhesion Molecule-1 | 9 | 2010 | 1125 | 0.460 |
Why?
|
| Models, Educational | 2 | 2014 | 373 | 0.460 |
Why?
|
| Tissue Engineering | 4 | 2023 | 1870 | 0.460 |
Why?
|
| Phospholipases | 8 | 1990 | 76 | 0.460 |
Why?
|
| Fatty Acids | 6 | 2021 | 1805 | 0.460 |
Why?
|
| Macrophage Activation | 2 | 2015 | 552 | 0.450 |
Why?
|
| Embryonic Stem Cells | 3 | 2015 | 1262 | 0.450 |
Why?
|
| Paracrine Communication | 2 | 2013 | 276 | 0.450 |
Why?
|
| Polycystic Kidney, Autosomal Recessive | 1 | 2013 | 31 | 0.450 |
Why?
|
| Blood Urea Nitrogen | 5 | 2017 | 186 | 0.440 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2020 | 1363 | 0.440 |
Why?
|
| Inflammation Mediators | 6 | 2021 | 1886 | 0.440 |
Why?
|
| Environmental Pollutants | 4 | 2016 | 1274 | 0.430 |
Why?
|
| Kidney Neoplasms | 9 | 2024 | 4241 | 0.430 |
Why?
|
| Cystatin C | 8 | 2018 | 270 | 0.430 |
Why?
|
| Toxicity Tests | 2 | 2010 | 114 | 0.420 |
Why?
|
| Immunohistochemistry | 30 | 2018 | 11070 | 0.420 |
Why?
|
| Capillaries | 1 | 2016 | 755 | 0.420 |
Why?
|
| Cell Proliferation | 11 | 2024 | 10425 | 0.420 |
Why?
|
| Biomedical Research | 6 | 2015 | 3421 | 0.420 |
Why?
|
| Carcinoma, Renal Cell | 9 | 2024 | 3159 | 0.410 |
Why?
|
| Testosterone | 3 | 2011 | 2471 | 0.400 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 8 | 2011 | 318 | 0.400 |
Why?
|
| Leydig Cells | 1 | 2011 | 55 | 0.400 |
Why?
|
| Ovulation | 2 | 2012 | 181 | 0.400 |
Why?
|
| Swine | 14 | 2019 | 5915 | 0.390 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 6 | 2000 | 489 | 0.390 |
Why?
|
| Cryosurgery | 1 | 2017 | 473 | 0.390 |
Why?
|
| Eicosanoids | 10 | 2013 | 282 | 0.390 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 3 | 2016 | 43 | 0.390 |
Why?
|
| Enzyme Activation | 32 | 2014 | 3592 | 0.380 |
Why?
|
| Brain Ischemia | 8 | 2000 | 3048 | 0.380 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2015 | 4369 | 0.380 |
Why?
|
| Cell Line | 27 | 2015 | 15598 | 0.380 |
Why?
|
| Oxidative Stress | 17 | 2015 | 3108 | 0.380 |
Why?
|
| Fertilization | 1 | 2012 | 199 | 0.380 |
Why?
|
| Arachidonic Acids | 11 | 2008 | 294 | 0.370 |
Why?
|
| Receptors, Calcitriol | 1 | 2013 | 360 | 0.370 |
Why?
|
| Mitochondria | 14 | 2016 | 3624 | 0.370 |
Why?
|
| Models, Biological | 14 | 2018 | 9462 | 0.370 |
Why?
|
| Phosphorylation | 24 | 2018 | 8311 | 0.370 |
Why?
|
| Glutathione Transferase | 3 | 2010 | 565 | 0.360 |
Why?
|
| Antigen Presentation | 2 | 2017 | 1254 | 0.360 |
Why?
|
| Hydrogen Peroxide | 9 | 2014 | 728 | 0.360 |
Why?
|
| Nephritis | 5 | 2021 | 146 | 0.360 |
Why?
|
| Immunity, Cellular | 3 | 2015 | 1559 | 0.360 |
Why?
|
| PAX2 Transcription Factor | 3 | 2017 | 86 | 0.350 |
Why?
|
| Signal Transduction | 33 | 2022 | 23397 | 0.350 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 1075 | 0.350 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2013 | 1636 | 0.350 |
Why?
|
| Sexual Maturation | 1 | 2011 | 261 | 0.340 |
Why?
|
| ROC Curve | 11 | 2024 | 3571 | 0.340 |
Why?
|
| Epidermal Growth Factor | 6 | 2023 | 700 | 0.340 |
Why?
|
| Homeostasis | 7 | 2016 | 3320 | 0.330 |
Why?
|
| Cadmium Chloride | 1 | 2009 | 9 | 0.330 |
Why?
|
| Time Factors | 38 | 2021 | 39947 | 0.330 |
Why?
|
| Blotting, Western | 14 | 2017 | 5031 | 0.330 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2009 | 73 | 0.320 |
Why?
|
| Gene Expression Regulation, Enzymologic | 9 | 2014 | 1170 | 0.320 |
Why?
|
| Up-Regulation | 14 | 2015 | 4116 | 0.320 |
Why?
|
| Rats, Inbred Strains | 22 | 2006 | 2090 | 0.310 |
Why?
|
| Hemodiafiltration | 1 | 2008 | 18 | 0.310 |
Why?
|
| Cardiopulmonary Bypass | 4 | 2018 | 1094 | 0.310 |
Why?
|
| Interleukin-18 | 8 | 2023 | 249 | 0.310 |
Why?
|
| Contrast Media | 3 | 2016 | 5310 | 0.310 |
Why?
|
| Critical Illness | 7 | 2017 | 2722 | 0.310 |
Why?
|
| Kidney Concentrating Ability | 4 | 2001 | 34 | 0.300 |
Why?
|
| Repressor Proteins | 7 | 2008 | 2978 | 0.300 |
Why?
|
| Mice, Transgenic | 14 | 2015 | 9533 | 0.300 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 6 | 2004 | 441 | 0.300 |
Why?
|
| Sensitivity and Specificity | 13 | 2013 | 14661 | 0.300 |
Why?
|
| Kidney Transplantation | 9 | 2010 | 4226 | 0.300 |
Why?
|
| DNA-Binding Proteins | 15 | 2004 | 9598 | 0.300 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 8 | 2015 | 2870 | 0.300 |
Why?
|
| Stem Cell Transplantation | 2 | 2007 | 1598 | 0.300 |
Why?
|
| Endoplasmic Reticulum | 3 | 2007 | 1133 | 0.300 |
Why?
|
| Reperfusion | 9 | 2001 | 270 | 0.290 |
Why?
|
| Wound Healing | 1 | 2019 | 2799 | 0.290 |
Why?
|
| Predictive Value of Tests | 17 | 2024 | 15257 | 0.290 |
Why?
|
| Vasopressins | 6 | 2001 | 351 | 0.280 |
Why?
|
| Toxicology | 1 | 2007 | 102 | 0.280 |
Why?
|
| RNA, Messenger | 20 | 2021 | 12785 | 0.280 |
Why?
|
| Clinical Medicine | 1 | 2008 | 145 | 0.280 |
Why?
|
| Cell Transplantation | 1 | 2009 | 472 | 0.280 |
Why?
|
| Cells, Cultured | 40 | 2018 | 18955 | 0.280 |
Why?
|
| Azotemia | 1 | 2006 | 8 | 0.280 |
Why?
|
| Ureteral Obstruction | 3 | 2019 | 293 | 0.280 |
Why?
|
| STAT3 Transcription Factor | 2 | 2022 | 870 | 0.280 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 4 | 2022 | 345 | 0.270 |
Why?
|
| Female | 98 | 2024 | 391875 | 0.270 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 8 | 2003 | 641 | 0.270 |
Why?
|
| Type C Phospholipases | 6 | 2007 | 287 | 0.270 |
Why?
|
| MAP Kinase Signaling System | 8 | 2014 | 1485 | 0.270 |
Why?
|
| Orchiectomy | 2 | 2006 | 463 | 0.270 |
Why?
|
| Nitric Oxide Synthase | 3 | 2004 | 906 | 0.260 |
Why?
|
| Leukocytes | 6 | 2010 | 2024 | 0.260 |
Why?
|
| Stem Cells | 2 | 2017 | 3522 | 0.260 |
Why?
|
| Glycolysis | 3 | 2021 | 832 | 0.260 |
Why?
|
| Hypertension | 9 | 2024 | 8527 | 0.260 |
Why?
|
| Rats, Wistar | 12 | 2017 | 1844 | 0.260 |
Why?
|
| COS Cells | 9 | 2008 | 1128 | 0.260 |
Why?
|
| Nuclear Proteins | 8 | 2020 | 5794 | 0.260 |
Why?
|
| Calcimycin | 9 | 2003 | 213 | 0.260 |
Why?
|
| Golgi Apparatus | 4 | 2008 | 404 | 0.260 |
Why?
|
| Receptors, Cell Surface | 5 | 2015 | 2819 | 0.260 |
Why?
|
| Enzyme Inhibitors | 17 | 2014 | 3710 | 0.250 |
Why?
|
| L-Lactate Dehydrogenase | 5 | 2015 | 411 | 0.250 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2007 | 217 | 0.250 |
Why?
|
| Serine Endopeptidases | 6 | 2010 | 1021 | 0.250 |
Why?
|
| Protein Structure, Tertiary | 7 | 2015 | 3792 | 0.250 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 5 | 2015 | 614 | 0.250 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 5 | 2015 | 1649 | 0.250 |
Why?
|
| Fibroblasts | 9 | 2015 | 4106 | 0.250 |
Why?
|
| Tyrosine | 5 | 2009 | 1438 | 0.250 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2021 | 12127 | 0.250 |
Why?
|
| Angiotensin II | 6 | 2015 | 848 | 0.250 |
Why?
|
| Stromal Cells | 2 | 2018 | 1330 | 0.240 |
Why?
|
| Critical Care | 5 | 2022 | 2697 | 0.240 |
Why?
|
| Case-Control Studies | 16 | 2021 | 22097 | 0.240 |
Why?
|
| Fatty Acid-Binding Proteins | 4 | 2017 | 296 | 0.240 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2021 | 1115 | 0.240 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 617 | 0.240 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2007 | 632 | 0.240 |
Why?
|
| Nitric Oxide Synthase Type II | 4 | 2009 | 512 | 0.240 |
Why?
|
| Cell Membrane | 8 | 2007 | 3685 | 0.240 |
Why?
|
| Neurotoxins | 2 | 1998 | 240 | 0.240 |
Why?
|
| Transcription, Genetic | 9 | 2020 | 7597 | 0.240 |
Why?
|
| Drug Evaluation, Preclinical | 5 | 2017 | 1337 | 0.240 |
Why?
|
| Pericytes | 2 | 2022 | 293 | 0.230 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2021 | 3629 | 0.230 |
Why?
|
| Lymphocyte Activation | 5 | 2017 | 5491 | 0.230 |
Why?
|
| Candida albicans | 3 | 2013 | 372 | 0.230 |
Why?
|
| Area Under Curve | 8 | 2015 | 1633 | 0.220 |
Why?
|
| Lung | 10 | 2007 | 9973 | 0.220 |
Why?
|
| Cell Cycle | 3 | 2012 | 2929 | 0.220 |
Why?
|
| Postoperative Complications | 7 | 2021 | 15627 | 0.220 |
Why?
|
| Cyclosporine | 3 | 2013 | 778 | 0.220 |
Why?
|
| Complement System Proteins | 2 | 2001 | 788 | 0.220 |
Why?
|
| Gene Expression | 14 | 2021 | 7582 | 0.220 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2008 | 1135 | 0.220 |
Why?
|
| HEK293 Cells | 4 | 2015 | 4277 | 0.210 |
Why?
|
| Gene Deletion | 8 | 2016 | 2667 | 0.210 |
Why?
|
| Oxygen | 12 | 2008 | 4222 | 0.210 |
Why?
|
| Docosahexaenoic Acids | 2 | 2007 | 908 | 0.210 |
Why?
|
| Prognosis | 20 | 2024 | 29551 | 0.210 |
Why?
|
| Saccharomyces cerevisiae Proteins | 5 | 1997 | 1841 | 0.210 |
Why?
|
| Loop of Henle | 3 | 2001 | 38 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-akt | 5 | 2015 | 2453 | 0.210 |
Why?
|
| Platelet Activating Factor | 2 | 1996 | 143 | 0.210 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 10 | 2017 | 3800 | 0.210 |
Why?
|
| Receptor Cross-Talk | 1 | 2003 | 116 | 0.210 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2003 | 476 | 0.210 |
Why?
|
| Ultrasonography | 1 | 2016 | 5966 | 0.210 |
Why?
|
| Calcitriol | 5 | 1992 | 296 | 0.210 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 2 | 2000 | 89 | 0.210 |
Why?
|
| Early Diagnosis | 5 | 2018 | 1183 | 0.210 |
Why?
|
| Arginine Vasopressin | 7 | 2008 | 125 | 0.210 |
Why?
|
| Trans-Activators | 4 | 2009 | 2858 | 0.210 |
Why?
|
| Nuclear Transfer Techniques | 1 | 2002 | 61 | 0.200 |
Why?
|
| Alternative Splicing | 3 | 2002 | 1091 | 0.200 |
Why?
|
| Chromium | 2 | 2016 | 132 | 0.200 |
Why?
|
| Zebrafish | 3 | 2015 | 3002 | 0.200 |
Why?
|
| Fibroblast Growth Factors | 2 | 2019 | 867 | 0.200 |
Why?
|
| Molecular Sequence Data | 22 | 2007 | 17639 | 0.200 |
Why?
|
| Th2 Cells | 2 | 2006 | 1054 | 0.200 |
Why?
|
| Alpha-Globulins | 1 | 2021 | 26 | 0.200 |
Why?
|
| Cysteine | 2 | 2003 | 892 | 0.200 |
Why?
|
| Education, Graduate | 1 | 2002 | 75 | 0.190 |
Why?
|
| Gene Expression Regulation | 13 | 2015 | 11900 | 0.190 |
Why?
|
| beta 2-Microglobulin | 3 | 2018 | 329 | 0.190 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2021 | 55 | 0.190 |
Why?
|
| Protein Kinase C | 8 | 2003 | 1202 | 0.190 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2006 | 1389 | 0.190 |
Why?
|
| Myocytes, Cardiac | 3 | 2015 | 1666 | 0.190 |
Why?
|
| Peroxidase | 6 | 2004 | 610 | 0.190 |
Why?
|
| Diuresis | 2 | 2018 | 106 | 0.190 |
Why?
|
| Epithelium | 9 | 2011 | 1603 | 0.190 |
Why?
|
| Radiation Chimera | 2 | 2015 | 216 | 0.180 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2015 | 697 | 0.180 |
Why?
|
| Hydrogels | 2 | 2024 | 723 | 0.180 |
Why?
|
| Transfection | 12 | 2009 | 5776 | 0.180 |
Why?
|
| Brain | 12 | 2012 | 27060 | 0.180 |
Why?
|
| Phenylalanine | 1 | 2002 | 366 | 0.180 |
Why?
|
| Receptors, Purinergic P2Y | 1 | 2020 | 23 | 0.180 |
Why?
|
| Neoplasm Proteins | 6 | 2015 | 3610 | 0.180 |
Why?
|
| Vasoconstriction | 3 | 2014 | 592 | 0.180 |
Why?
|
| Endothelium, Vascular | 6 | 2016 | 4430 | 0.180 |
Why?
|
| Renin-Angiotensin System | 3 | 2012 | 737 | 0.180 |
Why?
|
| Palmitic Acid | 1 | 2021 | 149 | 0.180 |
Why?
|
| Antihypertensive Agents | 3 | 2024 | 2018 | 0.180 |
Why?
|
| Biomimetics | 1 | 2022 | 172 | 0.180 |
Why?
|
| Ovalbumin | 4 | 2007 | 672 | 0.180 |
Why?
|
| Serum Albumin, Bovine | 1 | 2021 | 322 | 0.180 |
Why?
|
| Acute Disease | 7 | 2018 | 7230 | 0.180 |
Why?
|
| Platelet-Derived Growth Factor | 3 | 2015 | 618 | 0.180 |
Why?
|
| Protein Transport | 6 | 2009 | 1965 | 0.180 |
Why?
|
| Cadherins | 3 | 2016 | 904 | 0.180 |
Why?
|
| Antineoplastic Agents | 10 | 2017 | 13616 | 0.180 |
Why?
|
| Acetyltransferases | 1 | 2001 | 231 | 0.170 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 8 | 2006 | 687 | 0.170 |
Why?
|
| Middle Aged | 53 | 2024 | 220382 | 0.170 |
Why?
|
| Tissue Adhesions | 1 | 2021 | 218 | 0.170 |
Why?
|
| Cell Death | 8 | 2014 | 1664 | 0.170 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2020 | 126 | 0.170 |
Why?
|
| Gerbillinae | 6 | 2001 | 87 | 0.170 |
Why?
|
| Aging | 6 | 2019 | 8689 | 0.170 |
Why?
|
| Amino Acid Sequence | 18 | 2007 | 13445 | 0.170 |
Why?
|
| Endocytosis | 2 | 2021 | 958 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 19 | 2014 | 10759 | 0.170 |
Why?
|
| Cell Cycle Proteins | 4 | 2011 | 3446 | 0.170 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2001 | 435 | 0.170 |
Why?
|
| Protease Inhibitors | 3 | 2017 | 753 | 0.170 |
Why?
|
| Graft Rejection | 4 | 2010 | 4438 | 0.170 |
Why?
|
| Thapsigargin | 2 | 2013 | 102 | 0.170 |
Why?
|
| Podocytes | 3 | 2013 | 406 | 0.170 |
Why?
|
| Enzyme Induction | 3 | 2012 | 451 | 0.170 |
Why?
|
| STAT5 Transcription Factor | 1 | 2020 | 264 | 0.170 |
Why?
|
| Myofibroblasts | 1 | 2021 | 208 | 0.170 |
Why?
|
| Actins | 7 | 2018 | 2049 | 0.170 |
Why?
|
| Smoke Inhalation Injury | 1 | 1999 | 47 | 0.170 |
Why?
|
| Carrier Proteins | 4 | 2018 | 4936 | 0.170 |
Why?
|
| Precipitin Tests | 5 | 2002 | 815 | 0.170 |
Why?
|
| Deoxyglucose | 2 | 2015 | 333 | 0.160 |
Why?
|
| Phospholipids | 7 | 2005 | 786 | 0.160 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 1999 | 122 | 0.160 |
Why?
|
| Molecular Chaperones | 4 | 2003 | 755 | 0.160 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2020 | 183 | 0.160 |
Why?
|
| Heart Diseases | 1 | 2012 | 2785 | 0.160 |
Why?
|
| Prospective Studies | 25 | 2024 | 54339 | 0.160 |
Why?
|
| Muscle, Smooth, Vascular | 4 | 2014 | 1492 | 0.160 |
Why?
|
| Aquaporin 2 | 3 | 2008 | 126 | 0.160 |
Why?
|
| Pyrrolidines | 2 | 2013 | 338 | 0.160 |
Why?
|
| Prostaglandins | 3 | 2009 | 398 | 0.160 |
Why?
|
| Autolysis | 1 | 2018 | 13 | 0.160 |
Why?
|
| Rats, Inbred F344 | 6 | 2014 | 825 | 0.160 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2002 | 540 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 9 | 2012 | 4567 | 0.160 |
Why?
|
| Necrosis | 6 | 2013 | 1604 | 0.160 |
Why?
|
| Therapies, Investigational | 1 | 2019 | 111 | 0.160 |
Why?
|
| Morphogenesis | 1 | 2022 | 740 | 0.160 |
Why?
|
| Adult | 42 | 2024 | 220781 | 0.160 |
Why?
|
| Bone Marrow Cells | 6 | 2008 | 2416 | 0.160 |
Why?
|
| Green Fluorescent Proteins | 4 | 2012 | 2060 | 0.160 |
Why?
|
| Diet, Gluten-Free | 1 | 2021 | 283 | 0.160 |
Why?
|
| Nanomedicine | 1 | 2021 | 291 | 0.150 |
Why?
|
| Sulfones | 1 | 2021 | 447 | 0.150 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2020 | 303 | 0.150 |
Why?
|
| Microscopy, Fluorescence | 6 | 2012 | 2647 | 0.150 |
Why?
|
| Recombinant Proteins | 11 | 2005 | 6525 | 0.150 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2018 | 105 | 0.150 |
Why?
|
| Glucuronidase | 1 | 2019 | 202 | 0.150 |
Why?
|
| Cell Dedifferentiation | 1 | 2019 | 122 | 0.150 |
Why?
|
| Cilastatin | 1 | 2017 | 12 | 0.150 |
Why?
|
| Dogs | 7 | 2014 | 3839 | 0.150 |
Why?
|
| Hot Temperature | 5 | 1994 | 1440 | 0.150 |
Why?
|
| Specimen Handling | 2 | 2015 | 703 | 0.150 |
Why?
|
| Aged | 42 | 2024 | 168840 | 0.150 |
Why?
|
| Polycystic Kidney Diseases | 1 | 1998 | 133 | 0.150 |
Why?
|
| Career Choice | 2 | 2014 | 755 | 0.150 |
Why?
|
| Glutamic Acid | 4 | 1997 | 1175 | 0.150 |
Why?
|
| Biological Assay | 2 | 2012 | 626 | 0.150 |
Why?
|
| Interleukin-8 | 3 | 2010 | 696 | 0.150 |
Why?
|
| Egtazic Acid | 6 | 2013 | 169 | 0.150 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2023 | 850 | 0.150 |
Why?
|
| Fish Oils | 3 | 1991 | 481 | 0.150 |
Why?
|
| Sialoglycoproteins | 2 | 2015 | 315 | 0.150 |
Why?
|
| Amino Acid Motifs | 1 | 2020 | 931 | 0.150 |
Why?
|
| Dairy Products | 1 | 2021 | 491 | 0.150 |
Why?
|
| Dyneins | 1 | 2018 | 124 | 0.150 |
Why?
|
| Homeodomain Proteins | 3 | 2017 | 2413 | 0.150 |
Why?
|
| Base Sequence | 15 | 2018 | 12449 | 0.150 |
Why?
|
| Myocardium | 10 | 2015 | 4700 | 0.140 |
Why?
|
| Antigens | 5 | 2009 | 1446 | 0.140 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2021 | 311 | 0.140 |
Why?
|
| Growth Substances | 3 | 2002 | 768 | 0.140 |
Why?
|
| Flavonoids | 2 | 1999 | 444 | 0.140 |
Why?
|
| Disease Susceptibility | 4 | 2014 | 1790 | 0.140 |
Why?
|
| Nephrotic Syndrome | 1 | 2021 | 391 | 0.140 |
Why?
|
| Candidiasis | 2 | 2010 | 364 | 0.140 |
Why?
|
| United States | 14 | 2022 | 72202 | 0.140 |
Why?
|
| Phenanthridines | 1 | 1996 | 51 | 0.140 |
Why?
|
| Autoimmunity | 3 | 2017 | 1355 | 0.140 |
Why?
|
| Microfilament Proteins | 3 | 2015 | 1134 | 0.140 |
Why?
|
| Tissue Distribution | 5 | 2002 | 2265 | 0.140 |
Why?
|
| Education, Medical | 2 | 2014 | 1726 | 0.140 |
Why?
|
| Cell Survival | 12 | 2015 | 5790 | 0.140 |
Why?
|
| Animals, Newborn | 4 | 2017 | 2676 | 0.140 |
Why?
|
| Multiple Organ Failure | 2 | 2011 | 386 | 0.140 |
Why?
|
| Epoprostenol | 2 | 2013 | 246 | 0.140 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 2 | 2017 | 317 | 0.140 |
Why?
|
| Hemopexin | 1 | 2016 | 32 | 0.140 |
Why?
|
| Sodium-Glucose Transporter 2 | 2 | 2021 | 89 | 0.140 |
Why?
|
| Pericardium | 1 | 2021 | 675 | 0.140 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2018 | 152 | 0.140 |
Why?
|
| Sequence Homology, Amino Acid | 10 | 2007 | 2749 | 0.140 |
Why?
|
| Mice, Mutant Strains | 7 | 2012 | 1751 | 0.140 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2015 | 2860 | 0.140 |
Why?
|
| Heparin | 4 | 1999 | 1633 | 0.140 |
Why?
|
| Kidney Medulla | 5 | 2019 | 169 | 0.130 |
Why?
|
| Evidence-Based Medicine | 1 | 2008 | 3685 | 0.130 |
Why?
|
| Organ Transplantation | 2 | 2013 | 1154 | 0.130 |
Why?
|
| Ovarian Neoplasms | 2 | 2018 | 4879 | 0.130 |
Why?
|
| Dipeptides | 3 | 2014 | 391 | 0.130 |
Why?
|
| Nanostructures | 1 | 2021 | 552 | 0.130 |
Why?
|
| Abbreviated Injury Scale | 1 | 2016 | 49 | 0.130 |
Why?
|
| Urinalysis | 3 | 2018 | 368 | 0.130 |
Why?
|
| Kidney Cortex | 2 | 2014 | 169 | 0.130 |
Why?
|
| Binding Sites | 4 | 2020 | 6042 | 0.130 |
Why?
|
| Microsomes | 3 | 2004 | 251 | 0.130 |
Why?
|
| Mitochondrial Proteins | 6 | 2010 | 979 | 0.130 |
Why?
|
| Inositol Phosphates | 7 | 1992 | 176 | 0.130 |
Why?
|
| Leukotriene C4 | 4 | 2013 | 79 | 0.130 |
Why?
|
| Cell Nucleus | 3 | 2001 | 2906 | 0.130 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2019 | 613 | 0.130 |
Why?
|
| Sodium Cyanide | 1 | 2015 | 9 | 0.130 |
Why?
|
| Fungal Proteins | 3 | 1994 | 910 | 0.130 |
Why?
|
| Interleukin-1beta | 3 | 2018 | 997 | 0.130 |
Why?
|
| Indoleacetic Acids | 1 | 2015 | 44 | 0.130 |
Why?
|
| Gene Knockout Techniques | 2 | 2016 | 802 | 0.130 |
Why?
|
| Tetradecanoylphorbol Acetate | 7 | 2014 | 818 | 0.130 |
Why?
|
| Verapamil | 4 | 1986 | 242 | 0.130 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2015 | 828 | 0.130 |
Why?
|
| Proteome | 2 | 2002 | 1861 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 4 | 2018 | 7424 | 0.130 |
Why?
|
| Phenylbutyrates | 1 | 2015 | 72 | 0.130 |
Why?
|
| Organogenesis | 1 | 2017 | 215 | 0.130 |
Why?
|
| Hemodynamics | 8 | 2014 | 4167 | 0.120 |
Why?
|
| Benzamides | 1 | 2021 | 1370 | 0.120 |
Why?
|
| Immediate-Early Proteins | 2 | 2004 | 449 | 0.120 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2007 | 344 | 0.120 |
Why?
|
| Superoxide Dismutase | 4 | 2006 | 592 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 5 | 2003 | 472 | 0.120 |
Why?
|
| Haptoglobins | 1 | 2016 | 167 | 0.120 |
Why?
|
| Endothelins | 2 | 2015 | 127 | 0.120 |
Why?
|
| Phenotype | 6 | 2020 | 16585 | 0.120 |
Why?
|
| Down-Regulation | 5 | 2015 | 2911 | 0.120 |
Why?
|
| Mitosis | 3 | 2015 | 1186 | 0.120 |
Why?
|
| Ethanolamines | 1 | 2015 | 152 | 0.120 |
Why?
|
| Risk Factors | 14 | 2023 | 74055 | 0.120 |
Why?
|
| Molecular Weight | 7 | 2008 | 2188 | 0.120 |
Why?
|
| Microbubbles | 1 | 2016 | 135 | 0.120 |
Why?
|
| Ceramides | 2 | 2009 | 200 | 0.120 |
Why?
|
| Cytochromes c | 1 | 2015 | 173 | 0.120 |
Why?
|
| RNA Interference | 3 | 2021 | 2832 | 0.120 |
Why?
|
| Cell Respiration | 1 | 2015 | 202 | 0.120 |
Why?
|
| Interdisciplinary Studies | 1 | 2015 | 86 | 0.120 |
Why?
|
| Lipoylation | 1 | 2015 | 87 | 0.120 |
Why?
|
| RGS Proteins | 1 | 2014 | 74 | 0.120 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2006 | 754 | 0.120 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2024 | 1172 | 0.120 |
Why?
|
| Consensus Sequence | 2 | 1995 | 365 | 0.120 |
Why?
|
| Cell Lineage | 2 | 2017 | 2539 | 0.120 |
Why?
|
| Age Factors | 7 | 2020 | 18379 | 0.120 |
Why?
|
| Triazines | 1 | 1996 | 311 | 0.120 |
Why?
|
| Severity of Illness Index | 9 | 2020 | 15820 | 0.120 |
Why?
|
| Autopsy | 1 | 2018 | 1005 | 0.120 |
Why?
|
| RNA, Small Interfering | 3 | 2021 | 3428 | 0.120 |
Why?
|
| Tissue Culture Techniques | 1 | 2015 | 290 | 0.120 |
Why?
|
| Mice, 129 Strain | 2 | 2012 | 371 | 0.120 |
Why?
|
| Brain Injuries | 3 | 2002 | 2049 | 0.120 |
Why?
|
| Hydrogen-Ion Concentration | 8 | 2001 | 2498 | 0.120 |
Why?
|
| Genes, Synthetic | 1 | 2014 | 88 | 0.120 |
Why?
|
| NF-kappa B | 3 | 2017 | 2485 | 0.120 |
Why?
|
| Galactose | 1 | 2015 | 297 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 6 | 2005 | 2468 | 0.120 |
Why?
|
| Recombinant Fusion Proteins | 9 | 2006 | 3734 | 0.120 |
Why?
|
| Endpoint Determination | 1 | 2017 | 590 | 0.120 |
Why?
|
| Kinetics | 13 | 2007 | 6377 | 0.110 |
Why?
|
| Amino Acids, Essential | 1 | 2014 | 26 | 0.110 |
Why?
|
| Endothelial Cells | 4 | 2016 | 3541 | 0.110 |
Why?
|
| Foreskin | 1 | 2013 | 31 | 0.110 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2018 | 478 | 0.110 |
Why?
|
| Reactive Oxygen Species | 5 | 2015 | 2137 | 0.110 |
Why?
|
| Antigen-Presenting Cells | 2 | 2017 | 964 | 0.110 |
Why?
|
| MAP Kinase Kinase 1 | 4 | 2009 | 331 | 0.110 |
Why?
|
| Atherosclerosis | 3 | 2023 | 3407 | 0.110 |
Why?
|
| Training Support | 1 | 2014 | 109 | 0.110 |
Why?
|
| Lipopolysaccharides | 4 | 2008 | 2205 | 0.110 |
Why?
|
| Models, Animal | 5 | 2019 | 2111 | 0.110 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 5835 | 0.110 |
Why?
|
| Diphtheria Toxin | 1 | 2014 | 252 | 0.110 |
Why?
|
| Intensive Care Units | 5 | 2022 | 3742 | 0.110 |
Why?
|
| Tretinoin | 2 | 2013 | 519 | 0.110 |
Why?
|
| Neutrophils | 8 | 2020 | 3764 | 0.110 |
Why?
|
| Research | 1 | 2002 | 1977 | 0.110 |
Why?
|
| Bone Marrow Transplantation | 3 | 2006 | 2693 | 0.110 |
Why?
|
| Intracellular Membranes | 3 | 1990 | 389 | 0.110 |
Why?
|
| Neurons | 9 | 2011 | 9443 | 0.110 |
Why?
|
| Drug Delivery Systems | 3 | 2021 | 2224 | 0.110 |
Why?
|
| Metalloendopeptidases | 2 | 2007 | 393 | 0.110 |
Why?
|
| Regenerative Medicine | 1 | 2017 | 307 | 0.110 |
Why?
|
| Osmolar Concentration | 6 | 2001 | 661 | 0.110 |
Why?
|
| Receptors, Peptide | 1 | 2015 | 279 | 0.110 |
Why?
|
| Aristolochic Acids | 1 | 2012 | 11 | 0.110 |
Why?
|
| Standard of Care | 1 | 2017 | 550 | 0.110 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2017 | 857 | 0.110 |
Why?
|
| Listeria monocytogenes | 2 | 2007 | 250 | 0.110 |
Why?
|
| Arsenic | 1 | 2016 | 358 | 0.110 |
Why?
|
| Tissue Array Analysis | 3 | 2012 | 550 | 0.110 |
Why?
|
| Xenobiotics | 2 | 2014 | 70 | 0.100 |
Why?
|
| Genetic Vectors | 5 | 2019 | 3392 | 0.100 |
Why?
|
| Trichloroethylene | 1 | 2012 | 13 | 0.100 |
Why?
|
| Lithotripsy | 1 | 2013 | 140 | 0.100 |
Why?
|
| Uremia | 1 | 2014 | 201 | 0.100 |
Why?
|
| Connective Tissue | 1 | 2015 | 417 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 988 | 0.100 |
Why?
|
| Community-Institutional Relations | 1 | 2014 | 206 | 0.100 |
Why?
|
| Group V Phospholipases A2 | 4 | 2007 | 23 | 0.100 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2013 | 158 | 0.100 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2017 | 1445 | 0.100 |
Why?
|
| E2F Transcription Factors | 2 | 2004 | 269 | 0.100 |
Why?
|
| False Negative Reactions | 1 | 2013 | 573 | 0.100 |
Why?
|
| Ureteroscopy | 1 | 2013 | 146 | 0.100 |
Why?
|
| Group IB Phospholipases A2 | 1 | 2011 | 1 | 0.100 |
Why?
|
| Quality Control | 1 | 2015 | 826 | 0.100 |
Why?
|
| Endodermal Sinus Tumor | 1 | 2012 | 53 | 0.100 |
Why?
|
| Diuretics | 4 | 2008 | 610 | 0.100 |
Why?
|
| Folic Acid | 2 | 2003 | 1315 | 0.100 |
Why?
|
| Follow-Up Studies | 10 | 2021 | 39078 | 0.100 |
Why?
|
| Lipoproteins, LDL | 2 | 2008 | 642 | 0.100 |
Why?
|
| Metabolic Clearance Rate | 2 | 2010 | 361 | 0.100 |
Why?
|
| Paired Box Transcription Factors | 1 | 2012 | 206 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 2 | 2010 | 31 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2013 | 409 | 0.100 |
Why?
|
| RNA | 5 | 2015 | 2721 | 0.100 |
Why?
|
| Aminoglycosides | 1 | 2012 | 163 | 0.100 |
Why?
|
| Indomethacin | 6 | 2007 | 326 | 0.100 |
Why?
|
| Proteomics | 2 | 2021 | 3818 | 0.100 |
Why?
|
| RNA, Transfer | 1 | 2014 | 291 | 0.100 |
Why?
|
| Prostaglandins E | 2 | 1988 | 169 | 0.100 |
Why?
|
| Limit of Detection | 1 | 2012 | 272 | 0.100 |
Why?
|
| Vasoconstrictor Agents | 2 | 2008 | 653 | 0.100 |
Why?
|
| Clinical Trials as Topic | 4 | 2023 | 7996 | 0.100 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2015 | 617 | 0.100 |
Why?
|
| Mast Cells | 3 | 2007 | 1391 | 0.100 |
Why?
|
| Calcium-Binding Proteins | 2 | 1997 | 1069 | 0.100 |
Why?
|
| Ischemic Attack, Transient | 2 | 2001 | 878 | 0.100 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2013 | 591 | 0.100 |
Why?
|
| Water-Electrolyte Balance | 1 | 2012 | 325 | 0.100 |
Why?
|
| Health Priorities | 1 | 2014 | 374 | 0.100 |
Why?
|
| Sepsis | 5 | 2011 | 2583 | 0.090 |
Why?
|
| Regional Blood Flow | 2 | 2013 | 1487 | 0.090 |
Why?
|
| Histone Acetyltransferases | 2 | 2005 | 336 | 0.090 |
Why?
|
| Aquaporin 6 | 2 | 2001 | 44 | 0.090 |
Why?
|
| Receptors, Vasopressin | 2 | 2008 | 106 | 0.090 |
Why?
|
| Thymidine | 1 | 2011 | 299 | 0.090 |
Why?
|
| Adaptation, Physiological | 2 | 2011 | 1301 | 0.090 |
Why?
|
| DNA | 8 | 2018 | 7208 | 0.090 |
Why?
|
| Leukotrienes | 3 | 2003 | 231 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 5 | 2013 | 5778 | 0.090 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2011 | 186 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2013 | 4355 | 0.090 |
Why?
|
| United States Food and Drug Administration | 1 | 2019 | 1663 | 0.090 |
Why?
|
| Thiocarbamates | 2 | 2007 | 30 | 0.090 |
Why?
|
| Acetaminophen | 1 | 2015 | 554 | 0.090 |
Why?
|
| False Positive Reactions | 1 | 2013 | 956 | 0.090 |
Why?
|
| Nitric Oxide | 2 | 2018 | 2133 | 0.090 |
Why?
|
| Aluminum Compounds | 1 | 1990 | 55 | 0.090 |
Why?
|
| Uteroglobin | 2 | 2008 | 56 | 0.090 |
Why?
|
| Gene Transfer Techniques | 2 | 2009 | 1205 | 0.090 |
Why?
|
| Infertility | 1 | 1997 | 654 | 0.090 |
Why?
|
| Platinum | 1 | 2012 | 220 | 0.090 |
Why?
|
| Vasomotor System | 1 | 1991 | 207 | 0.090 |
Why?
|
| Pyridines | 5 | 2013 | 2868 | 0.090 |
Why?
|
| Indians, North American | 1 | 2014 | 353 | 0.090 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2011 | 480 | 0.090 |
Why?
|
| Education, Medical, Graduate | 2 | 2014 | 2367 | 0.090 |
Why?
|
| Drug Discovery | 1 | 2018 | 1054 | 0.090 |
Why?
|
| Thioacetamide | 1 | 2010 | 22 | 0.090 |
Why?
|
| Gene Targeting | 1 | 2014 | 838 | 0.090 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 2 | 2020 | 75 | 0.090 |
Why?
|
| Methyl Ethers | 1 | 2012 | 196 | 0.090 |
Why?
|
| Delivery of Health Care | 1 | 2008 | 5332 | 0.090 |
Why?
|
| Cyclin B2 | 1 | 2010 | 5 | 0.090 |
Why?
|
| Heart Failure | 3 | 2019 | 11653 | 0.090 |
Why?
|
| Immunity, Innate | 3 | 2015 | 3059 | 0.090 |
Why?
|
| Glutamates | 1 | 1991 | 389 | 0.090 |
Why?
|
| Nanotubes, Carbon | 1 | 2011 | 71 | 0.090 |
Why?
|
| Antigens, Ly | 2 | 1990 | 294 | 0.090 |
Why?
|
| DNA, Complementary | 5 | 2005 | 1992 | 0.090 |
Why?
|
| Cell Adhesion | 4 | 2011 | 3088 | 0.090 |
Why?
|
| Flow Cytometry | 5 | 2012 | 5865 | 0.090 |
Why?
|
| Chorionic Gonadotropin | 1 | 2012 | 457 | 0.090 |
Why?
|
| Metabolomics | 3 | 2017 | 1653 | 0.090 |
Why?
|
| Aquaporins | 2 | 2001 | 174 | 0.090 |
Why?
|
| Remission, Spontaneous | 1 | 2010 | 384 | 0.090 |
Why?
|
| Stochastic Processes | 1 | 2011 | 356 | 0.090 |
Why?
|
| Microvilli | 1 | 2010 | 234 | 0.080 |
Why?
|
| Muscle, Smooth | 3 | 2002 | 926 | 0.080 |
Why?
|
| Leukotriene B4 | 2 | 2001 | 280 | 0.080 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2012 | 716 | 0.080 |
Why?
|
| Metalloproteins | 1 | 1990 | 101 | 0.080 |
Why?
|
| Litter Size | 2 | 2000 | 49 | 0.080 |
Why?
|
| Delayed Graft Function | 1 | 2009 | 50 | 0.080 |
Why?
|
| Conserved Sequence | 4 | 2004 | 1164 | 0.080 |
Why?
|
| Protein Synthesis Inhibitors | 2 | 2007 | 189 | 0.080 |
Why?
|
| Genes, MHC Class II | 3 | 2005 | 451 | 0.080 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2011 | 161 | 0.080 |
Why?
|
| Diffusion of Innovation | 1 | 2014 | 726 | 0.080 |
Why?
|
| Cell Line, Transformed | 4 | 2013 | 868 | 0.080 |
Why?
|
| Membrane Lipids | 1 | 1990 | 252 | 0.080 |
Why?
|
| Macrophages | 6 | 2014 | 5764 | 0.080 |
Why?
|
| Immunoenzyme Techniques | 3 | 2008 | 1704 | 0.080 |
Why?
|
| Spleen | 2 | 2007 | 2296 | 0.080 |
Why?
|
| Gestational Age | 1 | 2018 | 3574 | 0.080 |
Why?
|
| Chemokine CXCL10 | 1 | 2010 | 316 | 0.080 |
Why?
|
| Codon, Nonsense | 1 | 2011 | 285 | 0.080 |
Why?
|
| Blood Pressure | 7 | 2018 | 8479 | 0.080 |
Why?
|
| Staining and Labeling | 2 | 2002 | 1083 | 0.080 |
Why?
|
| Kidney Calculi | 1 | 2013 | 463 | 0.080 |
Why?
|
| Infant, Newborn | 4 | 2020 | 26280 | 0.080 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 3 | 2002 | 477 | 0.080 |
Why?
|
| Proto-Oncogenes | 1 | 1990 | 321 | 0.080 |
Why?
|
| Antioxidants | 4 | 2008 | 1670 | 0.080 |
Why?
|
| Genome, Human | 2 | 2018 | 4423 | 0.080 |
Why?
|
| Cell Movement | 3 | 2011 | 5198 | 0.080 |
Why?
|
| Cytoskeleton | 2 | 2005 | 1167 | 0.080 |
Why?
|
| Macrophages, Alveolar | 2 | 2009 | 412 | 0.080 |
Why?
|
| Histocytochemistry | 1 | 2010 | 698 | 0.080 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2011 | 507 | 0.080 |
Why?
|
| Ki-67 Antigen | 1 | 2011 | 629 | 0.080 |
Why?
|
| Heart Failure, Systolic | 1 | 2010 | 135 | 0.080 |
Why?
|
| Okadaic Acid | 3 | 2008 | 67 | 0.080 |
Why?
|
| Plasmids | 3 | 2018 | 2274 | 0.080 |
Why?
|
| Biopsy | 5 | 2021 | 6765 | 0.080 |
Why?
|
| Mentors | 1 | 2014 | 660 | 0.080 |
Why?
|
| Prostaglandin Antagonists | 1 | 2008 | 28 | 0.080 |
Why?
|
| DNA Primers | 5 | 2012 | 2820 | 0.080 |
Why?
|
| Interdisciplinary Communication | 1 | 2014 | 931 | 0.080 |
Why?
|
| Soybean Proteins | 1 | 2008 | 55 | 0.080 |
Why?
|
| Cattle | 5 | 2011 | 3849 | 0.080 |
Why?
|
| Vanadates | 2 | 2007 | 82 | 0.080 |
Why?
|
| Potassium Channels | 2 | 2006 | 537 | 0.080 |
Why?
|
| Genetic Markers | 2 | 2013 | 2612 | 0.080 |
Why?
|
| Annexin A6 | 1 | 2008 | 4 | 0.080 |
Why?
|
| Phospholipases A2, Cytosolic | 1 | 2008 | 3 | 0.080 |
Why?
|
| CHO Cells | 3 | 2008 | 1389 | 0.080 |
Why?
|
| Risk Assessment | 8 | 2018 | 23953 | 0.080 |
Why?
|
| Biological Transport | 2 | 2010 | 2090 | 0.080 |
Why?
|
| Organ Preservation | 1 | 1992 | 379 | 0.080 |
Why?
|
| Diglycerides | 5 | 2013 | 177 | 0.080 |
Why?
|
| Butadienes | 2 | 2014 | 107 | 0.080 |
Why?
|
| T-Lymphocytes | 6 | 2012 | 10188 | 0.080 |
Why?
|
| Mutagenesis | 3 | 2012 | 1233 | 0.080 |
Why?
|
| Phenylmercury Compounds | 1 | 2007 | 3 | 0.080 |
Why?
|
| Cerebral Cortex | 3 | 2001 | 5764 | 0.080 |
Why?
|
| Zymosan | 2 | 2006 | 136 | 0.080 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2018 | 1554 | 0.080 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 26063 | 0.080 |
Why?
|
| Sodium | 5 | 1988 | 1589 | 0.070 |
Why?
|
| International Cooperation | 1 | 2014 | 1428 | 0.070 |
Why?
|
| Dihydrotestosterone | 2 | 2006 | 195 | 0.070 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 2568 | 0.070 |
Why?
|
| Radiology, Interventional | 1 | 2012 | 476 | 0.070 |
Why?
|
| Diagnostic Techniques, Urological | 1 | 2007 | 28 | 0.070 |
Why?
|
| Ovary | 1 | 2012 | 958 | 0.070 |
Why?
|
| Cohort Studies | 9 | 2021 | 41366 | 0.070 |
Why?
|
| Hemolysin Proteins | 1 | 2007 | 114 | 0.070 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 1992 | 2531 | 0.070 |
Why?
|
| Urea | 4 | 1988 | 444 | 0.070 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2001 | 283 | 0.070 |
Why?
|
| Metallothionein | 1 | 2007 | 61 | 0.070 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2009 | 326 | 0.070 |
Why?
|
| Cricetinae | 3 | 2008 | 2427 | 0.070 |
Why?
|
| Group II Phospholipases A2 | 2 | 2006 | 12 | 0.070 |
Why?
|
| Cricetulus | 2 | 2008 | 815 | 0.070 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2007 | 60 | 0.070 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2012 | 491 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 7 | 2005 | 9176 | 0.070 |
Why?
|
| Lysophospholipids | 3 | 2011 | 337 | 0.070 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2011 | 369 | 0.070 |
Why?
|
| Catalase | 2 | 2006 | 217 | 0.070 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 1504 | 0.070 |
Why?
|
| gamma-Glutamyltransferase | 3 | 2012 | 144 | 0.070 |
Why?
|
| Cystatins | 1 | 2007 | 55 | 0.070 |
Why?
|
| Acidosis | 2 | 1988 | 268 | 0.070 |
Why?
|
| Pleural Neoplasms | 1 | 2012 | 609 | 0.070 |
Why?
|
| Receptor, Muscarinic M1 | 1 | 2006 | 25 | 0.070 |
Why?
|
| Erythrocytes | 1 | 2016 | 2417 | 0.070 |
Why?
|
| Models, Statistical | 2 | 2012 | 5078 | 0.070 |
Why?
|
| Chelating Agents | 3 | 2013 | 386 | 0.070 |
Why?
|
| Phosphatidylserines | 1 | 2008 | 188 | 0.070 |
Why?
|
| Young Adult | 11 | 2021 | 59068 | 0.070 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 4 | 2009 | 352 | 0.070 |
Why?
|
| Reproducibility of Results | 5 | 2017 | 20078 | 0.070 |
Why?
|
| Eye Proteins | 1 | 2010 | 633 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3782 | 0.070 |
Why?
|
| Listeriosis | 1 | 2007 | 150 | 0.070 |
Why?
|
| Protein Phosphatase 2 | 1 | 2008 | 231 | 0.070 |
Why?
|
| Neoplasms | 3 | 2012 | 22083 | 0.070 |
Why?
|
| Valproic Acid | 1 | 2009 | 442 | 0.070 |
Why?
|
| Pregnancy | 7 | 2013 | 29831 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2017 | 2215 | 0.070 |
Why?
|
| Butylated Hydroxytoluene | 1 | 2006 | 8 | 0.070 |
Why?
|
| Immune Sera | 2 | 1999 | 613 | 0.070 |
Why?
|
| Dietary Fats | 2 | 1991 | 1994 | 0.070 |
Why?
|
| Cloning, Molecular | 8 | 1998 | 4174 | 0.070 |
Why?
|
| Mass Spectrometry | 3 | 2014 | 2189 | 0.070 |
Why?
|
| Proteins | 7 | 2006 | 6033 | 0.070 |
Why?
|
| F2-Isoprostanes | 1 | 2005 | 35 | 0.070 |
Why?
|
| Spinal Cord Injuries | 1 | 2014 | 924 | 0.070 |
Why?
|
| Caveolin 1 | 1 | 2008 | 255 | 0.070 |
Why?
|
| Endotoxins | 1 | 2008 | 521 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2010 | 2911 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2010 | 3777 | 0.070 |
Why?
|
| Neuroblastoma | 2 | 2006 | 1250 | 0.070 |
Why?
|
| Fura-2 | 4 | 1991 | 107 | 0.060 |
Why?
|
| Brain Death | 1 | 2009 | 356 | 0.060 |
Why?
|
| Mesothelioma | 1 | 2012 | 807 | 0.060 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2007 | 273 | 0.060 |
Why?
|
| Child | 12 | 2023 | 80086 | 0.060 |
Why?
|
| Terminology as Topic | 2 | 2015 | 1534 | 0.060 |
Why?
|
| Perfusion | 3 | 2002 | 1374 | 0.060 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2012 | 1517 | 0.060 |
Why?
|
| Cholesterol | 2 | 2012 | 2902 | 0.060 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2005 | 127 | 0.060 |
Why?
|
| Methacholine Chloride | 2 | 2007 | 220 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2007 | 457 | 0.060 |
Why?
|
| Methylmercury Compounds | 1 | 2006 | 102 | 0.060 |
Why?
|
| Fatty Acids, Nonesterified | 3 | 2003 | 393 | 0.060 |
Why?
|
| Hypertrophy | 3 | 2002 | 559 | 0.060 |
Why?
|
| Aged, 80 and over | 9 | 2019 | 58859 | 0.060 |
Why?
|
| Blotting, Northern | 3 | 1991 | 1545 | 0.060 |
Why?
|
| Hypoglycemic Agents | 2 | 2021 | 3076 | 0.060 |
Why?
|
| Organ Specificity | 2 | 2007 | 1956 | 0.060 |
Why?
|
| Protein Isoforms | 2 | 2007 | 1697 | 0.060 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2001 | 502 | 0.060 |
Why?
|
| Eosinophils | 2 | 2003 | 947 | 0.060 |
Why?
|
| Cell Line, Tumor | 7 | 2014 | 16945 | 0.060 |
Why?
|
| Free Radicals | 4 | 1991 | 238 | 0.060 |
Why?
|
| Calcium Channels, L-Type | 1 | 2006 | 242 | 0.060 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2004 | 37 | 0.060 |
Why?
|
| MAP Kinase Kinase 4 | 2 | 2003 | 149 | 0.060 |
Why?
|
| Superoxides | 1 | 2006 | 386 | 0.060 |
Why?
|
| Pesticides | 1 | 2007 | 294 | 0.060 |
Why?
|
| Mercury | 1 | 2007 | 288 | 0.060 |
Why?
|
| Caloric Restriction | 1 | 2007 | 299 | 0.060 |
Why?
|
| Sodium, Dietary | 1 | 2008 | 425 | 0.060 |
Why?
|
| Patient Selection | 1 | 2017 | 4240 | 0.060 |
Why?
|
| Radiography | 3 | 2012 | 6963 | 0.060 |
Why?
|
| Protein Binding | 3 | 2008 | 9340 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 5 | 2009 | 2423 | 0.060 |
Why?
|
| Nifedipine | 2 | 1986 | 221 | 0.060 |
Why?
|
| Mice, Inbred ICR | 4 | 2009 | 364 | 0.060 |
Why?
|
| Child, Preschool | 8 | 2021 | 42209 | 0.060 |
Why?
|
| Autoimmune Diseases | 1 | 2017 | 2247 | 0.060 |
Why?
|
| NAD | 2 | 2004 | 614 | 0.060 |
Why?
|
| Quinone Reductases | 3 | 1990 | 23 | 0.060 |
Why?
|
| Mitochondria, Heart | 1 | 1986 | 229 | 0.060 |
Why?
|
| Stress, Physiological | 3 | 2003 | 1400 | 0.060 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 1230 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2008 | 704 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-jun | 2 | 1995 | 285 | 0.060 |
Why?
|
| Potassium | 5 | 2006 | 1311 | 0.060 |
Why?
|
| Substrate Specificity | 6 | 1995 | 1792 | 0.060 |
Why?
|
| Chromatography, Gel | 3 | 1995 | 646 | 0.060 |
Why?
|
| Adolescent | 11 | 2021 | 88196 | 0.060 |
Why?
|
| Oxygen Consumption | 6 | 1990 | 1859 | 0.060 |
Why?
|
| Lysosomes | 2 | 2012 | 919 | 0.060 |
Why?
|
| Extracellular Matrix | 3 | 2018 | 1725 | 0.060 |
Why?
|
| Cyclin E | 1 | 2004 | 156 | 0.060 |
Why?
|
| Renin | 1 | 2006 | 639 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2004 | 458 | 0.060 |
Why?
|
| RNA, Neoplasm | 1 | 2007 | 749 | 0.060 |
Why?
|
| Genotype | 3 | 2015 | 12976 | 0.060 |
Why?
|
| Phalloidine | 1 | 2003 | 21 | 0.060 |
Why?
|
| Neutrophil Infiltration | 2 | 2020 | 387 | 0.060 |
Why?
|
| DNA Probes | 1 | 2005 | 544 | 0.060 |
Why?
|
| Virulence Factors | 1 | 2007 | 512 | 0.060 |
Why?
|
| Malates | 3 | 1990 | 34 | 0.060 |
Why?
|
| Chronic Disease | 4 | 2012 | 9309 | 0.060 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2007 | 3396 | 0.060 |
Why?
|
| Thiopental | 1 | 1983 | 55 | 0.060 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 2003 | 38 | 0.060 |
Why?
|
| Cell Size | 3 | 2003 | 624 | 0.060 |
Why?
|
| Cyclic AMP | 3 | 2013 | 1461 | 0.060 |
Why?
|
| Pyruvates | 3 | 1990 | 84 | 0.060 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 2 | 1994 | 221 | 0.060 |
Why?
|
| Hyperglycemia | 1 | 2012 | 1371 | 0.060 |
Why?
|
| Immunoblotting | 4 | 2010 | 1647 | 0.060 |
Why?
|
| Luminescent Proteins | 2 | 2009 | 836 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 2011 | 1745 | 0.060 |
Why?
|
| Galectins | 1 | 2006 | 295 | 0.060 |
Why?
|
| Acetylcysteine | 1 | 2005 | 260 | 0.060 |
Why?
|
| Caspase 3 | 4 | 2010 | 729 | 0.060 |
Why?
|
| Prevalence | 3 | 2020 | 15698 | 0.060 |
Why?
|
| Dithiothreitol | 1 | 2003 | 95 | 0.060 |
Why?
|
| Nitroarginine | 1 | 2003 | 66 | 0.050 |
Why?
|
| Extracellular Space | 4 | 1992 | 563 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2008 | 1135 | 0.050 |
Why?
|
| Mercuric Chloride | 2 | 2008 | 17 | 0.050 |
Why?
|
| Liver Transplantation | 1 | 2015 | 2332 | 0.050 |
Why?
|
| Capillary Leak Syndrome | 1 | 2003 | 34 | 0.050 |
Why?
|
| Cyanides | 2 | 2001 | 82 | 0.050 |
Why?
|
| Tunicamycin | 1 | 2003 | 108 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2011 | 1248 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 1 | 2005 | 1627 | 0.050 |
Why?
|
| Fluorides | 2 | 2016 | 134 | 0.050 |
Why?
|
| Lipid Metabolism | 3 | 2015 | 1899 | 0.050 |
Why?
|
| In Situ Hybridization | 2 | 2005 | 1900 | 0.050 |
Why?
|
| Proportional Hazards Models | 4 | 2020 | 12429 | 0.050 |
Why?
|
| Phosphatidylcholines | 5 | 2006 | 405 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2805 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2008 | 894 | 0.050 |
Why?
|
| Urology | 1 | 2008 | 400 | 0.050 |
Why?
|
| ADAM Proteins | 2 | 2014 | 237 | 0.050 |
Why?
|
| Nitriles | 2 | 2014 | 969 | 0.050 |
Why?
|
| Infant | 6 | 2021 | 36183 | 0.050 |
Why?
|
| Obesity | 2 | 2019 | 12918 | 0.050 |
Why?
|
| Chromatin | 1 | 2014 | 2951 | 0.050 |
Why?
|
| Phosphates | 2 | 2016 | 770 | 0.050 |
Why?
|
| Neural Inhibition | 1 | 2006 | 589 | 0.050 |
Why?
|
| Blood Platelets | 1 | 1993 | 2478 | 0.050 |
Why?
|
| Spironolactone | 1 | 2006 | 411 | 0.050 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2008 | 929 | 0.050 |
Why?
|
| Cloning, Organism | 1 | 2002 | 50 | 0.050 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2002 | 283 | 0.050 |
Why?
|
| Kidney Pelvis | 2 | 1980 | 186 | 0.050 |
Why?
|
| Education, Medical, Continuing | 1 | 2007 | 824 | 0.050 |
Why?
|
| Calreticulin | 1 | 2003 | 114 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 1991 | 1540 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7380 | 0.050 |
Why?
|
| Biotinylation | 1 | 2002 | 184 | 0.050 |
Why?
|
| Bacterial Toxins | 1 | 2007 | 932 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2007 | 2927 | 0.050 |
Why?
|
| HSP72 Heat-Shock Proteins | 1 | 2001 | 40 | 0.050 |
Why?
|
| Body Weight | 3 | 2007 | 4614 | 0.050 |
Why?
|
| Hydrolysis | 4 | 2005 | 665 | 0.050 |
Why?
|
| Cell Polarity | 3 | 2000 | 637 | 0.050 |
Why?
|
| Benzylisoquinolines | 1 | 2001 | 15 | 0.050 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 2047 | 0.050 |
Why?
|
| Cell Membrane Permeability | 4 | 1986 | 575 | 0.050 |
Why?
|
| Occupational Exposure | 1 | 2012 | 1811 | 0.050 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2001 | 56 | 0.050 |
Why?
|
| Clusterin | 2 | 2009 | 71 | 0.050 |
Why?
|
| Water Deprivation | 1 | 2001 | 19 | 0.050 |
Why?
|
| Lung Diseases | 2 | 2006 | 1909 | 0.050 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 2001 | 138 | 0.050 |
Why?
|
| Aquaporin 3 | 1 | 2001 | 14 | 0.050 |
Why?
|
| Antibodies | 3 | 2007 | 2421 | 0.050 |
Why?
|
| Transcription Factor DP1 | 1 | 2001 | 136 | 0.050 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2003 | 175 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2007 | 1567 | 0.050 |
Why?
|
| Culture Media, Serum-Free | 1 | 2001 | 148 | 0.050 |
Why?
|
| Clone Cells | 2 | 2002 | 1660 | 0.050 |
Why?
|
| Aquaporin 1 | 1 | 2001 | 57 | 0.050 |
Why?
|
| Cytoplasm | 2 | 2005 | 1511 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2013 | 3024 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 4 | 2010 | 6086 | 0.050 |
Why?
|
| Reference Values | 2 | 2014 | 4921 | 0.050 |
Why?
|
| Renal Artery Obstruction | 1 | 1982 | 219 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2013 | 17854 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2010 | 609 | 0.050 |
Why?
|
| Endothelin-1 | 2 | 2002 | 302 | 0.050 |
Why?
|
| Administration, Oral | 4 | 2012 | 4010 | 0.050 |
Why?
|
| Skin | 1 | 2015 | 4474 | 0.050 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 2 | 2004 | 80 | 0.050 |
Why?
|
| E2F1 Transcription Factor | 1 | 2001 | 178 | 0.050 |
Why?
|
| Tissue and Organ Procurement | 1 | 2009 | 950 | 0.050 |
Why?
|
| Cell Transdifferentiation | 1 | 2022 | 185 | 0.050 |
Why?
|
| Intestinal Polyps | 1 | 2001 | 104 | 0.050 |
Why?
|
| Polyglycolic Acid | 1 | 2002 | 405 | 0.050 |
Why?
|
| Oxidation-Reduction | 3 | 2003 | 2227 | 0.050 |
Why?
|
| Endothelium | 1 | 2003 | 765 | 0.050 |
Why?
|
| Natriuresis | 2 | 1999 | 105 | 0.050 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 2000 | 103 | 0.050 |
Why?
|
| Microtubules | 2 | 2018 | 1074 | 0.050 |
Why?
|
| Chromosome Mapping | 4 | 2000 | 4630 | 0.040 |
Why?
|
| Pulmonary Alveoli | 2 | 2003 | 650 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2010 | 3209 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2012 | 1953 | 0.040 |
Why?
|
| Arterioles | 2 | 2014 | 250 | 0.040 |
Why?
|
| Embryo Implantation | 1 | 2002 | 270 | 0.040 |
Why?
|
| Chemokines | 2 | 2020 | 960 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2011 | 2725 | 0.040 |
Why?
|
| Genomic Instability | 1 | 2004 | 709 | 0.040 |
Why?
|
| Complement Membrane Attack Complex | 2 | 1990 | 105 | 0.040 |
Why?
|
| Pheochromocytoma | 1 | 1982 | 328 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 11729 | 0.040 |
Why?
|
| Periplasmic Proteins | 1 | 2000 | 25 | 0.040 |
Why?
|
| Phosphoproteins | 4 | 2004 | 2444 | 0.040 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2002 | 312 | 0.040 |
Why?
|
| Microscopy, Electron | 4 | 2007 | 2560 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 9267 | 0.040 |
Why?
|
| Aquaporin 4 | 1 | 2001 | 161 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 3 | 2010 | 412 | 0.040 |
Why?
|
| Cardiomegaly | 2 | 2003 | 591 | 0.040 |
Why?
|
| Bronchoconstriction | 1 | 2000 | 142 | 0.040 |
Why?
|
| Sheep | 2 | 1999 | 1440 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 2 | 2007 | 1341 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2005 | 1807 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 9410 | 0.040 |
Why?
|
| Drinking | 1 | 2001 | 199 | 0.040 |
Why?
|
| Biology | 1 | 2002 | 289 | 0.040 |
Why?
|
| Embryo, Mammalian | 3 | 2008 | 1674 | 0.040 |
Why?
|
| Mice, Inbred Strains | 3 | 1999 | 1759 | 0.040 |
Why?
|
| Vimentin | 2 | 2006 | 255 | 0.040 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2000 | 62 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 2 | 2010 | 4413 | 0.040 |
Why?
|
| Protein Kinases | 3 | 1996 | 1607 | 0.040 |
Why?
|
| Respiratory Mucosa | 1 | 2003 | 439 | 0.040 |
Why?
|
| Protein Array Analysis | 2 | 2013 | 400 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2007 | 2770 | 0.040 |
Why?
|
| Positive-Pressure Respiration | 1 | 2004 | 638 | 0.040 |
Why?
|
| Airway Resistance | 1 | 2000 | 406 | 0.040 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2000 | 187 | 0.040 |
Why?
|
| Polyethylene Glycols | 2 | 2021 | 1189 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 1994 | 586 | 0.040 |
Why?
|
| Boston | 3 | 2021 | 9326 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 2 | 2001 | 2728 | 0.040 |
Why?
|
| Arginine | 1 | 2003 | 933 | 0.040 |
Why?
|
| Antiporters | 1 | 2000 | 278 | 0.040 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 1998 | 63 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 5 | 2002 | 6128 | 0.040 |
Why?
|
| Homovanillic Acid | 1 | 1998 | 75 | 0.040 |
Why?
|
| Cell Count | 2 | 2004 | 1834 | 0.040 |
Why?
|
| Middle Cerebral Artery | 1 | 2000 | 275 | 0.040 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 1998 | 34 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 8967 | 0.040 |
Why?
|
| Glucose | 2 | 2011 | 4342 | 0.040 |
Why?
|
| Rabbits | 2 | 2021 | 4780 | 0.040 |
Why?
|
| Receptors, Fibronectin | 1 | 1998 | 37 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2001 | 367 | 0.040 |
Why?
|
| Algorithms | 2 | 2017 | 14002 | 0.040 |
Why?
|
| Escherichia coli | 4 | 2001 | 4234 | 0.040 |
Why?
|
| Succinic Acid | 2 | 2012 | 86 | 0.040 |
Why?
|
| Rodentia | 1 | 2000 | 261 | 0.040 |
Why?
|
| Heat-Shock Response | 1 | 1999 | 179 | 0.040 |
Why?
|
| Cell Nucleolus | 1 | 1999 | 156 | 0.040 |
Why?
|
| Thiones | 2 | 2010 | 46 | 0.040 |
Why?
|
| Physiology | 1 | 1999 | 111 | 0.040 |
Why?
|
| Oxidants | 2 | 2011 | 169 | 0.040 |
Why?
|
| Treatment Outcome | 6 | 2021 | 64591 | 0.040 |
Why?
|
| Succinates | 2 | 1990 | 81 | 0.040 |
Why?
|
| Mass Screening | 1 | 2014 | 5424 | 0.040 |
Why?
|
| GTP-Binding Proteins | 3 | 1996 | 950 | 0.040 |
Why?
|
| Benzofurans | 3 | 1990 | 139 | 0.040 |
Why?
|
| Glycine | 2 | 2004 | 665 | 0.040 |
Why?
|
| Cyclooxygenase Inhibitors | 3 | 2007 | 361 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2007 | 10075 | 0.040 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2018 | 76 | 0.040 |
Why?
|
| Longevity | 2 | 2019 | 1062 | 0.040 |
Why?
|
| Polymorphism, Genetic | 3 | 2005 | 4287 | 0.040 |
Why?
|
| Thiophenes | 1 | 2002 | 569 | 0.040 |
Why?
|
| Crosses, Genetic | 2 | 2012 | 751 | 0.040 |
Why?
|
| Osteopontin | 3 | 2007 | 301 | 0.040 |
Why?
|
| Body Temperature Regulation | 1 | 1999 | 292 | 0.040 |
Why?
|
| Multigene Family | 1 | 2001 | 1077 | 0.040 |
Why?
|
| Dopamine Agents | 1 | 1998 | 189 | 0.040 |
Why?
|
| Respiration, Artificial | 3 | 2007 | 2622 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 2018 | 211 | 0.040 |
Why?
|
| Genes, Wilms Tumor | 1 | 1997 | 92 | 0.040 |
Why?
|
| Drug Interactions | 2 | 2006 | 1415 | 0.040 |
Why?
|
| Cell Physiological Phenomena | 1 | 1999 | 150 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2007 | 2895 | 0.040 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 1998 | 370 | 0.040 |
Why?
|
| Sex Characteristics | 2 | 2006 | 2633 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 2021 | 961 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 1983 | 1130 | 0.040 |
Why?
|
| Fibronectins | 1 | 2001 | 723 | 0.040 |
Why?
|
| Genes | 2 | 1999 | 1844 | 0.040 |
Why?
|
| Graft Survival | 3 | 2015 | 3806 | 0.040 |
Why?
|
| Cardiovascular Diseases | 4 | 2017 | 15476 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2009 | 3576 | 0.040 |
Why?
|
| Parathyroid Hormone | 2 | 2016 | 1802 | 0.040 |
Why?
|
| Immunosuppressive Agents | 2 | 2010 | 4168 | 0.040 |
Why?
|
| Aorta | 3 | 2014 | 2042 | 0.040 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1999 | 398 | 0.040 |
Why?
|
| Monocytes | 3 | 2020 | 2572 | 0.040 |
Why?
|
| Puromycin Aminonucleoside | 2 | 2007 | 7 | 0.040 |
Why?
|
| Freezing | 1 | 2018 | 310 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2002 | 2113 | 0.040 |
Why?
|
| Reproduction | 1 | 2002 | 645 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 2001 | 1250 | 0.040 |
Why?
|
| Analysis of Variance | 3 | 2012 | 6230 | 0.040 |
Why?
|
| Lung Neoplasms | 3 | 2015 | 13312 | 0.040 |
Why?
|
| Chromatography, Ion Exchange | 3 | 1995 | 296 | 0.040 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2015 | 460 | 0.040 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIb | 1 | 2016 | 10 | 0.030 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1982 | 732 | 0.030 |
Why?
|
| Pulmonary Artery | 2 | 1996 | 1938 | 0.030 |
Why?
|
| Substantia Nigra | 1 | 1998 | 350 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5296 | 0.030 |
Why?
|
| Cell-Matrix Junctions | 1 | 2016 | 21 | 0.030 |
Why?
|
| Oligomycins | 2 | 1986 | 20 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2012 | 4316 | 0.030 |
Why?
|
| Membrane Potentials | 4 | 2006 | 1094 | 0.030 |
Why?
|
| Registries | 1 | 2013 | 8216 | 0.030 |
Why?
|
| Chemotactic Factors, Eosinophil | 1 | 1996 | 40 | 0.030 |
Why?
|
| Pulmonary Circulation | 1 | 1999 | 743 | 0.030 |
Why?
|
| Stress Fibers | 1 | 2016 | 55 | 0.030 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2017 | 516 | 0.030 |
Why?
|
| Microfluidics | 1 | 2022 | 653 | 0.030 |
Why?
|
| Vertebrates | 1 | 1998 | 227 | 0.030 |
Why?
|
| Imidazoles | 2 | 1999 | 1179 | 0.030 |
Why?
|
| Lectins, C-Type | 2 | 2010 | 584 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2018 | 437 | 0.030 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 2 | 1986 | 20 | 0.030 |
Why?
|
| Digitonin | 2 | 1986 | 26 | 0.030 |
Why?
|
| Polyamines | 1 | 1997 | 133 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2006 | 2975 | 0.030 |
Why?
|
| Genes, jun | 1 | 1995 | 69 | 0.030 |
Why?
|
| Parenteral Nutrition, Total | 2 | 1988 | 304 | 0.030 |
Why?
|
| 3T3 Cells | 4 | 2000 | 1084 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2018 | 794 | 0.030 |
Why?
|
| Azepines | 1 | 2018 | 329 | 0.030 |
Why?
|
| Risk | 2 | 2020 | 9605 | 0.030 |
Why?
|
| Aminoquinolines | 2 | 1986 | 107 | 0.030 |
Why?
|
| Chromatography, Agarose | 1 | 1995 | 29 | 0.030 |
Why?
|
| Pediatrics | 2 | 2010 | 3593 | 0.030 |
Why?
|
| Alkaloids | 2 | 2001 | 192 | 0.030 |
Why?
|
| Mammals | 2 | 1999 | 1132 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2013 | 15867 | 0.030 |
Why?
|
| Selectins | 1 | 1996 | 101 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1995 | 779 | 0.030 |
Why?
|
| Bucladesine | 2 | 1986 | 118 | 0.030 |
Why?
|
| Kidney Tubules, Distal | 2 | 1991 | 42 | 0.030 |
Why?
|
| Caspases | 3 | 2004 | 876 | 0.030 |
Why?
|
| Interleukin-5 | 1 | 1996 | 269 | 0.030 |
Why?
|
| Myocardial Contraction | 3 | 1986 | 1516 | 0.030 |
Why?
|
| Rats, Inbred WKY | 2 | 1995 | 151 | 0.030 |
Why?
|
| Carboplatin | 1 | 2018 | 793 | 0.030 |
Why?
|
| Receptors, Cytokine | 1 | 1996 | 258 | 0.030 |
Why?
|
| Angiotensin II Type 2 Receptor Blockers | 1 | 2014 | 7 | 0.030 |
Why?
|
| Thyroid Hormones | 1 | 2018 | 404 | 0.030 |
Why?
|
| Heart | 3 | 2007 | 4391 | 0.030 |
Why?
|
| Pyruvic Acid | 2 | 1986 | 203 | 0.030 |
Why?
|
| Excitatory Amino Acids | 1 | 1994 | 17 | 0.030 |
Why?
|
| Thromboxane B2 | 1 | 1995 | 143 | 0.030 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 2015 | 27 | 0.030 |
Why?
|
| Chemokines, CC | 1 | 1996 | 283 | 0.030 |
Why?
|
| Fluorescein-5-isothiocyanate | 2 | 2007 | 222 | 0.030 |
Why?
|
| Isoproterenol | 2 | 1986 | 395 | 0.030 |
Why?
|
| Drug Resistance | 2 | 1998 | 1597 | 0.030 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2014 | 60 | 0.030 |
Why?
|
| Anodontia | 1 | 2015 | 50 | 0.030 |
Why?
|
| Calcium Channel Blockers | 3 | 2006 | 694 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1984 | 1807 | 0.030 |
Why?
|
| Protamines | 1 | 1995 | 112 | 0.030 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2010 | 586 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2021 | 8611 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 1998 | 859 | 0.030 |
Why?
|
| Shock, Hemorrhagic | 1 | 2016 | 223 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2021 | 792 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2002 | 3609 | 0.030 |
Why?
|
| Dependovirus | 1 | 2019 | 715 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2008 | 3975 | 0.030 |
Why?
|
| Pharmacokinetics | 1 | 2014 | 86 | 0.030 |
Why?
|
| Survival Rate | 2 | 2021 | 12698 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2021 | 80430 | 0.030 |
Why?
|
| Hospital Mortality | 4 | 2017 | 5283 | 0.030 |
Why?
|
| Ethyl Methanesulfonate | 2 | 1990 | 29 | 0.030 |
Why?
|
| Eating | 1 | 2001 | 1535 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 1995 | 321 | 0.030 |
Why?
|
| Chemokine CCL5 | 1 | 2014 | 215 | 0.030 |
Why?
|
| Vinblastine | 1 | 2015 | 488 | 0.030 |
Why?
|
| Etoposide | 1 | 2015 | 634 | 0.030 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1994 | 168 | 0.030 |
Why?
|
| Receptors, Mitogen | 2 | 1990 | 61 | 0.030 |
Why?
|
| Deoxycytidine | 1 | 2018 | 874 | 0.030 |
Why?
|
| Convalescence | 1 | 1994 | 105 | 0.030 |
Why?
|
| Histidine | 1 | 1994 | 308 | 0.030 |
Why?
|
| Gene Library | 1 | 1996 | 1059 | 0.030 |
Why?
|
| Vitamin K | 1 | 1996 | 318 | 0.030 |
Why?
|
| Mexico | 1 | 2016 | 761 | 0.030 |
Why?
|
| Basophils | 1 | 1996 | 405 | 0.030 |
Why?
|
| Program Development | 2 | 2012 | 1297 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2001 | 1337 | 0.030 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 2 | 1990 | 56 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 10180 | 0.030 |
Why?
|
| Diagnosis, Differential | 3 | 2015 | 12969 | 0.030 |
Why?
|
| DNA, Antisense | 1 | 1993 | 44 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 12054 | 0.030 |
Why?
|
| Lupus Nephritis | 1 | 2017 | 317 | 0.030 |
Why?
|
| Injections, Spinal | 1 | 2014 | 317 | 0.030 |
Why?
|
| Anaphylaxis | 1 | 2000 | 757 | 0.030 |
Why?
|
| Brain Edema | 1 | 1997 | 604 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2018 | 915 | 0.030 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1996 | 664 | 0.030 |
Why?
|
| Mitogens | 1 | 1993 | 230 | 0.030 |
Why?
|
| Carcinoma, Small Cell | 1 | 2015 | 420 | 0.030 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 1995 | 502 | 0.030 |
Why?
|
| Serum Albumin | 1 | 2016 | 675 | 0.030 |
Why?
|
| Sweden | 1 | 2016 | 1378 | 0.030 |
Why?
|
| Hemostasis | 1 | 1996 | 467 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 2005 | 2529 | 0.030 |
Why?
|
| Comorbidity | 2 | 2020 | 10494 | 0.030 |
Why?
|
| Dimethyl Sulfoxide | 2 | 1992 | 251 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2013 | 174 | 0.030 |
Why?
|
| Receptors, Chemokine | 1 | 1996 | 653 | 0.030 |
Why?
|
| Membranes | 1 | 1993 | 165 | 0.030 |
Why?
|
| Respiration | 1 | 1999 | 1657 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2018 | 802 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2014 | 545 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 1999 | 957 | 0.030 |
Why?
|
| Homozygote | 1 | 1997 | 1794 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2014 | 522 | 0.030 |
Why?
|
| Cerebral Infarction | 1 | 1997 | 982 | 0.030 |
Why?
|
| Vasodilator Agents | 2 | 1988 | 973 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 8519 | 0.030 |
Why?
|
| Hybridomas | 2 | 1990 | 442 | 0.030 |
Why?
|
| Genetic Variation | 3 | 2021 | 6570 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 2005 | 2483 | 0.030 |
Why?
|
| Phosphatidylinositols | 2 | 1990 | 282 | 0.030 |
Why?
|
| Triazoles | 1 | 2018 | 903 | 0.030 |
Why?
|
| Electron Transport | 2 | 1990 | 210 | 0.030 |
Why?
|
| Pyrazines | 1 | 2018 | 1199 | 0.030 |
Why?
|
| tert-Butyl Alcohol | 1 | 2012 | 3 | 0.030 |
Why?
|
| Simian virus 40 | 1 | 1993 | 291 | 0.030 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 1994 | 377 | 0.030 |
Why?
|
| Corpus Striatum | 1 | 1998 | 1235 | 0.030 |
Why?
|
| NG-Nitroarginine Methyl Ester | 2 | 2003 | 260 | 0.030 |
Why?
|
| Acetylcholine | 1 | 1994 | 628 | 0.030 |
Why?
|
| Cardiovascular System | 1 | 1999 | 835 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2015 | 932 | 0.020 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2013 | 282 | 0.020 |
Why?
|
| Intestines | 1 | 2021 | 1909 | 0.020 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2012 | 107 | 0.020 |
Why?
|
| Nephrolithiasis | 1 | 2013 | 115 | 0.020 |
Why?
|
| Resuscitation | 1 | 2016 | 661 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2014 | 481 | 0.020 |
Why?
|
| Dactinomycin | 1 | 1991 | 304 | 0.020 |
Why?
|
| Cycloheximide | 1 | 1991 | 343 | 0.020 |
Why?
|
| Credentialing | 1 | 2012 | 116 | 0.020 |
Why?
|
| Calgranulin A | 1 | 1992 | 80 | 0.020 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 2 | 1990 | 899 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2012 | 465 | 0.020 |
Why?
|
| Calgranulin B | 1 | 1992 | 86 | 0.020 |
Why?
|
| Phospholipases A2, Calcium-Independent | 1 | 2011 | 11 | 0.020 |
Why?
|
| Eosinophilia | 1 | 1996 | 560 | 0.020 |
Why?
|
| DNA Replication | 1 | 2018 | 1418 | 0.020 |
Why?
|
| New Zealand | 1 | 2012 | 357 | 0.020 |
Why?
|
| Least-Squares Analysis | 1 | 2012 | 370 | 0.020 |
Why?
|
| Fellowships and Scholarships | 2 | 2012 | 1117 | 0.020 |
Why?
|
| Lipoxygenase | 1 | 1991 | 72 | 0.020 |
Why?
|
| Lipid Peroxides | 1 | 1991 | 74 | 0.020 |
Why?
|
| Viral Load | 1 | 2020 | 3329 | 0.020 |
Why?
|
| Oxygenases | 1 | 1991 | 59 | 0.020 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 1991 | 64 | 0.020 |
Why?
|
| Drug Synergism | 3 | 1994 | 1755 | 0.020 |
Why?
|
| Blood Proteins | 1 | 2016 | 1174 | 0.020 |
Why?
|
| Absorption | 1 | 2011 | 243 | 0.020 |
Why?
|
| Early Growth Response Protein 1 | 1 | 1991 | 132 | 0.020 |
Why?
|
| Ketoconazole | 1 | 1991 | 97 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2017 | 1438 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2001 | 3445 | 0.020 |
Why?
|
| Periodicals as Topic | 1 | 2002 | 1463 | 0.020 |
Why?
|
| Arachidonate 5-Lipoxygenase | 2 | 2003 | 128 | 0.020 |
Why?
|
| Heterozygote | 1 | 1997 | 2798 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2015 | 1340 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1994 | 1693 | 0.020 |
Why?
|
| Information Systems | 1 | 2013 | 396 | 0.020 |
Why?
|
| Spinal Cord | 2 | 2014 | 1817 | 0.020 |
Why?
|
| Streptozocin | 1 | 2011 | 193 | 0.020 |
Why?
|
| Epitopes | 2 | 1994 | 2504 | 0.020 |
Why?
|
| Oliguria | 2 | 2007 | 21 | 0.020 |
Why?
|
| Liver | 3 | 2016 | 7531 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2011 | 197 | 0.020 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 1990 | 124 | 0.020 |
Why?
|
| Lead | 1 | 2016 | 879 | 0.020 |
Why?
|
| Misoprostol | 1 | 2011 | 93 | 0.020 |
Why?
|
| Research Design | 1 | 2006 | 6168 | 0.020 |
Why?
|
| Osmotic Pressure | 2 | 1980 | 139 | 0.020 |
Why?
|
| Alopecia | 1 | 2015 | 411 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 3587 | 0.020 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 1991 | 224 | 0.020 |
Why?
|
| Hydrolases | 1 | 1991 | 147 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2021 | 5236 | 0.020 |
Why?
|
| Phosphotyrosine | 1 | 1991 | 455 | 0.020 |
Why?
|
| Staurosporine | 1 | 1991 | 242 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2000 | 2821 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 1610 | 0.020 |
Why?
|
| Telemetry | 1 | 2011 | 199 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2012 | 611 | 0.020 |
Why?
|
| Length of Stay | 2 | 2018 | 6413 | 0.020 |
Why?
|
| Aluminum | 1 | 1990 | 152 | 0.020 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2010 | 60 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 3 | 1999 | 4735 | 0.020 |
Why?
|
| Japan | 1 | 2014 | 1366 | 0.020 |
Why?
|
| Growth Disorders | 1 | 2015 | 653 | 0.020 |
Why?
|
| alpha-Macroglobulins | 1 | 2009 | 60 | 0.020 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2011 | 266 | 0.020 |
Why?
|
| Photomicrography | 1 | 2009 | 71 | 0.020 |
Why?
|
| Blood Vessels | 1 | 1975 | 1113 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 2 | 2008 | 1959 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2011 | 915 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 1994 | 1197 | 0.020 |
Why?
|
| beta Catenin | 1 | 2014 | 1040 | 0.020 |
Why?
|
| Chlorides | 2 | 1993 | 665 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 1994 | 1982 | 0.020 |
Why?
|
| Adenosine | 1 | 2014 | 804 | 0.020 |
Why?
|
| Amines | 1 | 2011 | 281 | 0.020 |
Why?
|
| Sequence Alignment | 3 | 2000 | 2180 | 0.020 |
Why?
|
| Inositol | 1 | 1990 | 215 | 0.020 |
Why?
|
| S100 Proteins | 1 | 2009 | 218 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2011 | 552 | 0.020 |
Why?
|
| Temperature | 2 | 1995 | 2228 | 0.020 |
Why?
|
| Mucins | 1 | 2012 | 568 | 0.020 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2010 | 270 | 0.020 |
Why?
|
| CDC2 Protein Kinase | 1 | 2010 | 213 | 0.020 |
Why?
|
| Gallic Acid | 1 | 1988 | 24 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2009 | 151 | 0.020 |
Why?
|
| Potassium Dichromate | 1 | 2008 | 4 | 0.020 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2012 | 286 | 0.020 |
Why?
|
| Rats, Zucker | 1 | 2008 | 131 | 0.020 |
Why?
|
| Retinol-Binding Proteins | 1 | 1988 | 67 | 0.020 |
Why?
|
| Mice, Nude | 2 | 2009 | 3603 | 0.020 |
Why?
|
| Spiro Compounds | 1 | 2008 | 68 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1991 | 412 | 0.020 |
Why?
|
| Macromolecular Substances | 2 | 2007 | 1435 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2012 | 616 | 0.020 |
Why?
|
| Stroke | 1 | 2011 | 9745 | 0.020 |
Why?
|
| Peroxynitrous Acid | 1 | 2008 | 40 | 0.020 |
Why?
|
| Hydrochlorothiazide | 1 | 2008 | 94 | 0.020 |
Why?
|
| Esophagus | 1 | 1994 | 1030 | 0.020 |
Why?
|
| Mitochondria, Liver | 2 | 1987 | 190 | 0.020 |
Why?
|
| Caseins | 1 | 2008 | 103 | 0.020 |
Why?
|
| Liver Cirrhosis | 2 | 2010 | 1934 | 0.020 |
Why?
|
| Aminopeptidases | 1 | 1988 | 95 | 0.020 |
Why?
|
| Dizocilpine Maleate | 1 | 2008 | 172 | 0.020 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 1988 | 94 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 4923 | 0.020 |
Why?
|
| Galactosamine | 1 | 2007 | 26 | 0.020 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2010 | 427 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2012 | 1571 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2018 | 2007 | 0.020 |
Why?
|
| Communication | 1 | 2002 | 3868 | 0.020 |
Why?
|
| NADP | 1 | 2008 | 226 | 0.020 |
Why?
|
| Drug Carriers | 1 | 2012 | 706 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2008 | 271 | 0.020 |
Why?
|
| Asthma | 1 | 2006 | 6195 | 0.020 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2014 | 1017 | 0.020 |
Why?
|
| Mutation | 6 | 2015 | 30025 | 0.020 |
Why?
|
| Calmodulin | 1 | 1988 | 218 | 0.020 |
Why?
|
| Carbocyanines | 1 | 1987 | 175 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 1995 | 1690 | 0.020 |
Why?
|
| Phloretin | 1 | 1987 | 16 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 3072 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2008 | 427 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2024 | 4674 | 0.020 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 1990 | 540 | 0.020 |
Why?
|
| Massachusetts | 1 | 2020 | 8826 | 0.020 |
Why?
|
| Pyrimidinones | 1 | 2010 | 384 | 0.020 |
Why?
|
| Age of Onset | 1 | 2014 | 3302 | 0.020 |
Why?
|
| Integrases | 1 | 2009 | 516 | 0.020 |
Why?
|
| Phosphoinositide Phospholipase C | 1 | 2007 | 28 | 0.020 |
Why?
|
| Dibucaine | 1 | 1986 | 7 | 0.020 |
Why?
|
| ATP Synthetase Complexes | 1 | 1986 | 5 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2008 | 8579 | 0.020 |
Why?
|
| Superior Cervical Ganglion | 1 | 2006 | 33 | 0.020 |
Why?
|
| Eicosapentaenoic Acid | 1 | 1991 | 560 | 0.020 |
Why?
|
| Receptors, AMPA | 1 | 2008 | 336 | 0.020 |
Why?
|
| Receptors, Leptin | 1 | 2008 | 350 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2008 | 342 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2011 | 964 | 0.020 |
Why?
|
| Genome | 1 | 1995 | 1739 | 0.020 |
Why?
|
| Catheterization, Central Venous | 1 | 2012 | 527 | 0.020 |
Why?
|
| Logistic Models | 2 | 2015 | 13240 | 0.020 |
Why?
|
| Norbornanes | 1 | 2006 | 10 | 0.020 |
Why?
|
| Receptors, Angiotensin | 1 | 1987 | 141 | 0.020 |
Why?
|
| Losartan | 1 | 2008 | 265 | 0.020 |
Why?
|
| Maze Learning | 1 | 2008 | 482 | 0.020 |
Why?
|
| Urothelium | 1 | 2008 | 269 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2012 | 1176 | 0.020 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1986 | 110 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 1998 | 0.020 |
Why?
|
| Claudins | 1 | 2007 | 117 | 0.020 |
Why?
|
| Nanotechnology | 1 | 2012 | 712 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2010 | 1153 | 0.020 |
Why?
|
| Proton-Translocating ATPases | 1 | 1986 | 112 | 0.020 |
Why?
|
| APACHE | 1 | 2007 | 267 | 0.020 |
Why?
|
| Puromycin | 1 | 1986 | 42 | 0.020 |
Why?
|
| Collagen | 1 | 2015 | 2637 | 0.020 |
Why?
|
| Chemokine CCL8 | 1 | 2006 | 17 | 0.020 |
Why?
|
| Phospholipid Ethers | 1 | 2005 | 9 | 0.020 |
Why?
|
| Sphingolipids | 1 | 2008 | 174 | 0.020 |
Why?
|
| Glycoproteins | 1 | 1994 | 2207 | 0.020 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2010 | 653 | 0.020 |
Why?
|
| Ruthenium Red | 1 | 1986 | 19 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 2757 | 0.020 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 2006 | 47 | 0.020 |
Why?
|
| Isoprostanes | 1 | 2005 | 19 | 0.020 |
Why?
|
| Bromides | 1 | 2005 | 22 | 0.020 |
Why?
|
| Cause of Death | 1 | 2017 | 3686 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 1990 | 1608 | 0.020 |
Why?
|
| Gammaproteobacteria | 1 | 2006 | 28 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2009 | 509 | 0.020 |
Why?
|
| Potassium Channel Blockers | 1 | 2006 | 161 | 0.020 |
Why?
|
| Acetylglucosamine | 1 | 2007 | 189 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2008 | 877 | 0.020 |
Why?
|
| Potassium Compounds | 1 | 2005 | 42 | 0.020 |
Why?
|
| China | 1 | 2012 | 2339 | 0.020 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2006 | 82 | 0.020 |
Why?
|
| Isotopes | 1 | 2006 | 125 | 0.020 |
Why?
|
| Nephrosis | 1 | 1986 | 43 | 0.020 |
Why?
|
| Cats | 2 | 1999 | 975 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2009 | 943 | 0.020 |
Why?
|
| Trypsin | 1 | 1986 | 496 | 0.020 |
Why?
|
| Pain | 1 | 2001 | 5075 | 0.020 |
Why?
|
| Ouabain | 1 | 1986 | 247 | 0.020 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 1987 | 350 | 0.020 |
Why?
|
| src Homology Domains | 1 | 2006 | 361 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 3418 | 0.020 |
Why?
|
| Cell Separation | 1 | 2011 | 1720 | 0.020 |
Why?
|
| Phosphotransferases | 1 | 1986 | 303 | 0.020 |
Why?
|
| Consciousness | 1 | 2011 | 601 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2009 | 891 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 2 | 1997 | 255 | 0.020 |
Why?
|
| Larva | 1 | 2007 | 508 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3631 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2019 | 3956 | 0.020 |
Why?
|
| Brain Diseases | 1 | 1994 | 1544 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2010 | 1336 | 0.020 |
Why?
|
| Azoxymethane | 1 | 2005 | 35 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2006 | 311 | 0.020 |
Why?
|
| Morpholines | 1 | 2008 | 580 | 0.020 |
Why?
|
| Cadaver | 1 | 2009 | 1354 | 0.020 |
Why?
|
| Adenine Nucleotides | 1 | 1985 | 111 | 0.020 |
Why?
|
| Dextrans | 1 | 2007 | 573 | 0.020 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2006 | 350 | 0.020 |
Why?
|
| alpha-Synuclein | 1 | 2012 | 750 | 0.020 |
Why?
|
| Coloring Agents | 1 | 1987 | 559 | 0.020 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2006 | 213 | 0.020 |
Why?
|
| Nephritis, Interstitial | 1 | 2006 | 155 | 0.020 |
Why?
|
| Epinephrine | 1 | 2008 | 792 | 0.020 |
Why?
|
| Heart Ventricles | 3 | 1987 | 3815 | 0.020 |
Why?
|
| Living Donors | 1 | 2009 | 639 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2009 | 677 | 0.020 |
Why?
|
| Mathematics | 1 | 1986 | 707 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2007 | 584 | 0.020 |
Why?
|
| Aldehydes | 1 | 2005 | 170 | 0.020 |
Why?
|
| Phagosomes | 1 | 2006 | 199 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2008 | 1528 | 0.010 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 1183 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 1993 | 4108 | 0.010 |
Why?
|
| Injections | 1 | 2007 | 829 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1991 | 2114 | 0.010 |
Why?
|
| Acetates | 1 | 2005 | 321 | 0.010 |
Why?
|
| Delphi Technique | 1 | 2008 | 835 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2006 | 931 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2017 | 3028 | 0.010 |
Why?
|
| Random Allocation | 1 | 2008 | 2388 | 0.010 |
Why?
|
| Cyclooxygenase 1 | 1 | 2004 | 97 | 0.010 |
Why?
|
| Catalysis | 1 | 2005 | 774 | 0.010 |
Why?
|
| Choline | 1 | 1986 | 514 | 0.010 |
Why?
|
| Early Detection of Cancer | 1 | 2018 | 3183 | 0.010 |
Why?
|
| Diagnosis-Related Groups | 1 | 2005 | 449 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2012 | 3157 | 0.010 |
Why?
|
| Cytochalasin B | 1 | 2003 | 74 | 0.010 |
Why?
|
| Cysts | 1 | 2009 | 681 | 0.010 |
Why?
|
| Sodium Chloride | 2 | 2003 | 588 | 0.010 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2006 | 431 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 2852 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2012 | 2123 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 11096 | 0.010 |
Why?
|
| Coronary Circulation | 1 | 1989 | 1565 | 0.010 |
Why?
|
| Medicare | 1 | 2021 | 6732 | 0.010 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2004 | 169 | 0.010 |
Why?
|
| Co-Repressor Proteins | 1 | 2004 | 191 | 0.010 |
Why?
|
| Anthracenes | 1 | 2003 | 83 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2009 | 1967 | 0.010 |
Why?
|
| Edema | 1 | 2007 | 769 | 0.010 |
Why?
|
| Dietary Proteins | 1 | 2008 | 953 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-raf | 2 | 1994 | 203 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 2007 | 733 | 0.010 |
Why?
|
| Cardiac Output | 1 | 2005 | 837 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 1986 | 665 | 0.010 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2008 | 1110 | 0.010 |
Why?
|
| Endosomes | 1 | 2006 | 520 | 0.010 |
Why?
|
| F-Box Proteins | 1 | 2004 | 201 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2013 | 4000 | 0.010 |
Why?
|
| Fluorescent Dyes | 2 | 1990 | 1900 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1985 | 686 | 0.010 |
Why?
|
| Lithium | 1 | 1986 | 596 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2012 | 2104 | 0.010 |
Why?
|
| Sirolimus | 1 | 2010 | 1533 | 0.010 |
Why?
|
| Tritium | 1 | 2003 | 707 | 0.010 |
Why?
|
| Propranolol | 1 | 1984 | 489 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1986 | 1975 | 0.010 |
Why?
|
| Dimerization | 1 | 2004 | 891 | 0.010 |
Why?
|
| Regression Analysis | 2 | 2009 | 6340 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2000 | 800 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2008 | 2073 | 0.010 |
Why?
|
| Quinolines | 1 | 1987 | 764 | 0.010 |
Why?
|
| Nitrobenzenes | 1 | 2002 | 66 | 0.010 |
Why?
|
| Focus Groups | 1 | 2008 | 1404 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2009 | 2215 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2005 | 11095 | 0.010 |
Why?
|
| Hypertension, Renovascular | 1 | 1982 | 116 | 0.010 |
Why?
|
| Hyperkalemia | 1 | 1984 | 233 | 0.010 |
Why?
|
| Decidua | 1 | 2002 | 82 | 0.010 |
Why?
|
| Vitamin D | 1 | 2016 | 3303 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2003 | 574 | 0.010 |
Why?
|
| Midazolam | 1 | 1983 | 266 | 0.010 |
Why?
|
| Hydroxycholesterols | 1 | 2001 | 25 | 0.010 |
Why?
|
| Phosphocreatine | 1 | 1982 | 261 | 0.010 |
Why?
|
| Combined Modality Therapy | 2 | 2008 | 8522 | 0.010 |
Why?
|
| Oxidoreductases | 1 | 2004 | 412 | 0.010 |
Why?
|
| Prostaglandin D2 | 1 | 2002 | 108 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2008 | 3097 | 0.010 |
Why?
|
| Vanadium | 1 | 1981 | 54 | 0.010 |
Why?
|
| Aldosterone | 1 | 2006 | 866 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2007 | 2642 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2003 | 748 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2006 | 1561 | 0.010 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 2001 | 93 | 0.010 |
Why?
|
| Biphenyl Compounds | 1 | 2006 | 1003 | 0.010 |
Why?
|
| Isomerism | 1 | 2001 | 197 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 2016 | 4443 | 0.010 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2003 | 553 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 1983 | 427 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 1994 | 2163 | 0.010 |
Why?
|
| Freund's Adjuvant | 1 | 2001 | 148 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 2006 | 855 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2009 | 4808 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1983 | 897 | 0.010 |
Why?
|
| Inulin | 1 | 1980 | 68 | 0.010 |
Why?
|
| Leukocyte Count | 2 | 1995 | 1596 | 0.010 |
Why?
|
| Anisomycin | 1 | 2000 | 27 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2002 | 282 | 0.010 |
Why?
|
| Lipoproteins | 1 | 2005 | 881 | 0.010 |
Why?
|
| Motor Activity | 1 | 2011 | 2710 | 0.010 |
Why?
|
| Myocardial Infarction | 3 | 2011 | 11453 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2009 | 2242 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 2007 | 1494 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 1992 | 2875 | 0.010 |
Why?
|
| Peptide Fragments | 2 | 2008 | 5105 | 0.010 |
Why?
|
| Endothelial Growth Factors | 1 | 2003 | 673 | 0.010 |
Why?
|
| Ionophores | 1 | 2000 | 107 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2008 | 1877 | 0.010 |
Why?
|
| Tetrazoles | 1 | 2006 | 907 | 0.010 |
Why?
|
| Leptin | 1 | 2008 | 1593 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8623 | 0.010 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2001 | 181 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2016 | 3796 | 0.010 |
Why?
|
| Phospholipase D | 1 | 2000 | 67 | 0.010 |
Why?
|
| Lymphokines | 1 | 2003 | 927 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2015 | 4020 | 0.010 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2001 | 145 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2005 | 1668 | 0.010 |
Why?
|
| Urine | 1 | 2001 | 362 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 2000 | 455 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2005 | 1037 | 0.010 |
Why?
|
| Trachea | 1 | 2005 | 1089 | 0.010 |
Why?
|
| Cations, Divalent | 2 | 1990 | 168 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2004 | 1494 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2008 | 12320 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 2000 | 316 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 1737 | 0.010 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2005 | 621 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 2003 | 773 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2008 | 2493 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2002 | 461 | 0.010 |
Why?
|
| Haplorhini | 1 | 1999 | 529 | 0.010 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2010 | 1524 | 0.010 |
Why?
|
| Adipocytes | 1 | 2006 | 1192 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 6297 | 0.010 |
Why?
|
| Curriculum | 1 | 2012 | 3732 | 0.010 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2000 | 361 | 0.010 |
Why?
|
| Uterus | 1 | 2002 | 649 | 0.010 |
Why?
|
| Hypersensitivity | 1 | 2007 | 1157 | 0.010 |
Why?
|
| Organ Size | 1 | 2003 | 2252 | 0.010 |
Why?
|
| Nucleic Acid Heteroduplexes | 1 | 1997 | 46 | 0.010 |
Why?
|
| DNA, Ribosomal | 1 | 1999 | 299 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 6330 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2003 | 1674 | 0.010 |
Why?
|
| Endovascular Procedures | 1 | 2012 | 2179 | 0.010 |
Why?
|
| Lipids | 2 | 2003 | 3342 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2012 | 2875 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2000 | 705 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 1 | 1999 | 497 | 0.010 |
Why?
|
| Sulfonamides | 2 | 2002 | 1973 | 0.010 |
Why?
|
| WT1 Proteins | 1 | 1997 | 184 | 0.010 |
Why?
|
| Receptors, CCR3 | 1 | 1996 | 62 | 0.010 |
Why?
|
| Microcirculation | 1 | 2001 | 1269 | 0.010 |
Why?
|
| Capsules | 1 | 1997 | 191 | 0.010 |
Why?
|
| Chemokine CCL11 | 1 | 1996 | 128 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2002 | 1753 | 0.010 |
Why?
|
| Serine | 1 | 2000 | 828 | 0.010 |
Why?
|
| Histamine Release | 1 | 1996 | 135 | 0.010 |
Why?
|
| Activating Transcription Factor 2 | 1 | 1995 | 44 | 0.010 |
Why?
|
| Infertility, Female | 1 | 2002 | 758 | 0.010 |
Why?
|
| Incidence | 1 | 2014 | 21322 | 0.010 |
Why?
|
| Leucine Zippers | 1 | 1995 | 116 | 0.010 |
Why?
|
| Amiloride | 1 | 1995 | 116 | 0.010 |
Why?
|
| Rats, Inbred SHR | 1 | 1995 | 186 | 0.010 |
Why?
|
| Gels | 1 | 1997 | 419 | 0.010 |
Why?
|
| Protein Folding | 1 | 1999 | 867 | 0.010 |
Why?
|
| Injections, Intra-Arterial | 1 | 1975 | 182 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1996 | 436 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2003 | 1929 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 1404 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 2008 | 3835 | 0.010 |
Why?
|
| Factor Xa | 1 | 1996 | 167 | 0.010 |
Why?
|
| Phosphatidylethanolamines | 1 | 1995 | 129 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2004 | 1889 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 2000 | 1228 | 0.010 |
Why?
|
| Silicones | 1 | 1975 | 227 | 0.010 |
Why?
|
| Adenoviridae | 1 | 1998 | 1084 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1988 | 4748 | 0.010 |
Why?
|
| Inpatients | 1 | 2005 | 2545 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 2 | 1990 | 685 | 0.010 |
Why?
|
| Renal Artery | 1 | 1995 | 351 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 1988 | 3541 | 0.010 |
Why?
|
| Phylogeny | 1 | 2001 | 2806 | 0.010 |
Why?
|
| Colchicine | 1 | 1994 | 260 | 0.010 |
Why?
|
| Crystallization | 1 | 1994 | 533 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 1995 | 778 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 1998 | 985 | 0.010 |
Why?
|
| Bacteria | 1 | 2004 | 2217 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1994 | 532 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2009 | 5662 | 0.010 |
Why?
|
| Alleles | 1 | 2004 | 6908 | 0.010 |
Why?
|
| Salmon | 1 | 1992 | 34 | 0.010 |
Why?
|
| Receptors, Calcitonin | 1 | 1992 | 34 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1992 | 346 | 0.010 |
Why?
|
| Peptides | 1 | 2004 | 4338 | 0.010 |
Why?
|
| Anesthesia | 1 | 1983 | 1588 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1992 | 365 | 0.010 |
Why?
|
| Esophagogastric Junction | 1 | 1994 | 343 | 0.010 |
Why?
|
| Insulin | 1 | 1987 | 6591 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2003 | 3486 | 0.010 |
Why?
|
| Chloride Channels | 1 | 1993 | 221 | 0.010 |
Why?
|
| Receptors, Parathyroid Hormone | 1 | 1992 | 332 | 0.010 |
Why?
|
| Manganese | 1 | 1994 | 395 | 0.010 |
Why?
|
| Tubulin | 1 | 1994 | 692 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2001 | 2272 | 0.010 |
Why?
|
| Calcitonin | 1 | 1992 | 329 | 0.010 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 1992 | 327 | 0.010 |
Why?
|
| Probenecid | 1 | 1990 | 73 | 0.010 |
Why?
|
| Magnesium | 1 | 1994 | 809 | 0.010 |
Why?
|
| Culture Media | 1 | 1992 | 899 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2000 | 2803 | 0.010 |
Why?
|
| Concanavalin A | 1 | 1989 | 190 | 0.010 |
Why?
|
| Autoantigens | 1 | 1994 | 876 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2000 | 4903 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 1992 | 901 | 0.010 |
Why?
|
| Nigericin | 1 | 1987 | 10 | 0.000 |
Why?
|
| 2,4-Dinitrophenol | 1 | 1987 | 13 | 0.000 |
Why?
|
| Dinitrophenols | 1 | 1987 | 56 | 0.000 |
Why?
|
| Pregnancy Complications | 1 | 2002 | 2946 | 0.000 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 1988 | 112 | 0.000 |
Why?
|
| Major Histocompatibility Complex | 1 | 1990 | 927 | 0.000 |
Why?
|
| Antigens, Differentiation | 1 | 1989 | 910 | 0.000 |
Why?
|
| Osteoblasts | 1 | 1992 | 1143 | 0.000 |
Why?
|
| Chlorpromazine | 1 | 1986 | 111 | 0.000 |
Why?
|
| Bacterial Proteins | 1 | 2000 | 3842 | 0.000 |
Why?
|
| Depression, Chemical | 1 | 1986 | 184 | 0.000 |
Why?
|
| Structure-Activity Relationship | 1 | 1990 | 3075 | 0.000 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1984 | 100 | 0.000 |
Why?
|
| Allopurinol | 1 | 1986 | 198 | 0.000 |
Why?
|
| Interleukin-4 | 1 | 1988 | 1130 | 0.000 |
Why?
|
| Isoantibodies | 1 | 1988 | 674 | 0.000 |
Why?
|
| Interleukins | 1 | 1988 | 782 | 0.000 |
Why?
|
| Vasodilation | 1 | 1986 | 961 | 0.000 |
Why?
|
| Light | 1 | 1987 | 1351 | 0.000 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1990 | 1405 | 0.000 |
Why?
|
| Microchemistry | 1 | 1979 | 54 | 0.000 |
Why?
|
| Injections, Intravenous | 1 | 1981 | 1379 | 0.000 |
Why?
|
| Diet | 1 | 1997 | 8058 | 0.000 |
Why?
|
| Lymph Nodes | 1 | 1989 | 3469 | 0.000 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1987 | 2204 | 0.000 |
Why?
|
| Water | 1 | 1981 | 1409 | 0.000 |
Why?
|
| Melanoma | 1 | 1993 | 5704 | 0.000 |
Why?
|